CA2751402A1 - Composes d'indol substitues en tant que modulateurs du recepteur 1 de la bradykinine - Google Patents

Composes d'indol substitues en tant que modulateurs du recepteur 1 de la bradykinine Download PDF

Info

Publication number: CA2751402A1
Authority: CA; Canada
Prior art keywords: alkyl; stands; phenyl; cycloalkyl; aryl
Prior art date: 2009-02-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA2751402A

Other languages

English (en)

Inventor

Stefan Schunk

Melanie Reich

Michael Engels

Tieno Germann

Ruth Jostock

Sabine Hees

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Gruenenthal GmbH

Original Assignee

Gruenenthal GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-02-04

Filing date

2010-02-02

Publication date

2010-08-12

2010-02-02 Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH

2010-08-12 Publication of CA2751402A1 publication Critical patent/CA2751402A1/fr

Status Abandoned legal-status Critical Current

Links

150000002475 indoles Chemical class 0.000 title abstract description 20
102000017916 BDKRB1 Human genes 0.000 title description 2
108060003359 BDKRB1 Proteins 0.000 title description 2
150000001875 compounds Chemical class 0.000 claims abstract description 74
125000001424 substituent group Chemical group 0.000 claims description 213
239000000203 mixture Substances 0.000 claims description 155
125000003118 aryl group Chemical group 0.000 claims description 154
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 148
125000001072 heteroaryl group Chemical group 0.000 claims description 143
-1 indole compound Chemical class 0.000 claims description 143
125000004076 pyridyl group Chemical group 0.000 claims description 129
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 97
125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 96
229910052731 fluorine Inorganic materials 0.000 claims description 96
229910052801 chlorine Inorganic materials 0.000 claims description 94
125000002947 alkylene group Chemical group 0.000 claims description 85
125000001544 thienyl group Chemical group 0.000 claims description 83
125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 77
125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 73
125000002883 imidazolyl group Chemical group 0.000 claims description 66
125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 65
125000001425 triazolyl group Chemical group 0.000 claims description 64
125000000335 thiazolyl group Chemical group 0.000 claims description 63
125000000714 pyrimidinyl group Chemical group 0.000 claims description 59
125000000753 cycloalkyl group Chemical group 0.000 claims description 58
125000003161 (C1-C6) alkylene group Chemical group 0.000 claims description 49
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 49
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 32
229910052740 iodine Inorganic materials 0.000 claims description 32
229910052794 bromium Inorganic materials 0.000 claims description 31
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 29
229910052739 hydrogen Inorganic materials 0.000 claims description 28
229910052717 sulfur Inorganic materials 0.000 claims description 20
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 20
208000002193 Pain Diseases 0.000 claims description 19
229940126601 medicinal product Drugs 0.000 claims description 18
229920006395 saturated elastomer Polymers 0.000 claims description 17
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 16
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 15
125000001624 naphthyl group Chemical group 0.000 claims description 15
229910052757 nitrogen Inorganic materials 0.000 claims description 15
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 14
SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 13
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 12
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 12
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 12
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 12
125000005842 heteroatom Chemical group 0.000 claims description 11
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 11
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 11
229910052760 oxygen Inorganic materials 0.000 claims description 11
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 10
125000002393 azetidinyl group Chemical group 0.000 claims description 10
125000004432 carbon atom Chemical group C* 0.000 claims description 10
150000001923 cyclic compounds Chemical class 0.000 claims description 10
125000002541 furyl group Chemical group 0.000 claims description 10
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 10
125000004433 nitrogen atom Chemical group N* 0.000 claims description 10
125000000719 pyrrolidinyl group Chemical group 0.000 claims description 10
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 9
125000003386 piperidinyl group Chemical group 0.000 claims description 9
238000002360 preparation method Methods 0.000 claims description 9
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
206010061218 Inflammation Diseases 0.000 claims description 7
201000010099 disease Diseases 0.000 claims description 7
150000003839 salts Chemical class 0.000 claims description 7
206010065390 Inflammatory pain Diseases 0.000 claims description 6
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 claims description 6
230000004054 inflammatory process Effects 0.000 claims description 6
208000004296 neuralgia Diseases 0.000 claims description 6
208000021722 neuropathic pain Diseases 0.000 claims description 6
208000000094 Chronic Pain Diseases 0.000 claims description 5
208000005298 acute pain Diseases 0.000 claims description 5
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 5
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 5
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 5
125000001041 indolyl group Chemical group 0.000 claims description 5
208000009935 visceral pain Diseases 0.000 claims description 5
208000022559 Inflammatory bowel disease Diseases 0.000 claims description 4
208000008589 Obesity Diseases 0.000 claims description 4
206010040070 Septic Shock Diseases 0.000 claims description 4
125000004122 cyclic group Chemical group 0.000 claims description 4
150000003840 hydrochlorides Chemical class 0.000 claims description 4
235000020824 obesity Nutrition 0.000 claims description 4
125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 4
230000036303 septic shock Effects 0.000 claims description 4
VEEGZPWAAPPXRB-BJMVGYQFSA-N (3e)-3-(1h-imidazol-5-ylmethylidene)-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C/C1=CN=CN1 VEEGZPWAAPPXRB-BJMVGYQFSA-N 0.000 claims description 3
208000012902 Nervous system disease Diseases 0.000 claims description 3
208000025966 Neurological disease Diseases 0.000 claims description 3
208000025747 Rheumatic disease Diseases 0.000 claims description 3
229940121369 angiogenesis inhibitor Drugs 0.000 claims description 3
239000004037 angiogenesis inhibitor Substances 0.000 claims description 3
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims description 3
125000005872 benzooxazolyl group Chemical group 0.000 claims description 3
125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 claims description 3
125000004988 dibenzothienyl group Chemical group C1(=CC=CC=2SC3=C(C21)C=CC=C3)* 0.000 claims description 3
150000002391 heterocyclic compounds Chemical class 0.000 claims description 3
125000004430 oxygen atom Chemical group O* 0.000 claims description 3
125000004344 phenylpropyl group Chemical group 0.000 claims description 3
125000003373 pyrazinyl group Chemical group 0.000 claims description 3
125000002098 pyridazinyl group Chemical group 0.000 claims description 3
125000000168 pyrrolyl group Chemical group 0.000 claims description 3
230000010410 reperfusion Effects 0.000 claims description 3
210000002345 respiratory system Anatomy 0.000 claims description 3
208000011580 syndromic disease Diseases 0.000 claims description 3
150000007577 5-membered cyclic compounds Chemical class 0.000 claims description 2
150000007578 6-membered cyclic compounds Chemical class 0.000 claims description 2
150000007579 7-membered cyclic compounds Chemical class 0.000 claims description 2
208000019695 Migraine disease Diseases 0.000 claims description 2
125000005605 benzo group Chemical group 0.000 claims description 2
206010012601 diabetes mellitus Diseases 0.000 claims description 2
125000005509 dibenzothiophenyl group Chemical group 0.000 claims description 2
206010027599 migraine Diseases 0.000 claims description 2
125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 2
238000000034 method Methods 0.000 abstract description 20
239000003814 drug Substances 0.000 abstract 2
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 362
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 353
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 310
239000000243 solution Substances 0.000 description 236
125000000217 alkyl group Chemical group 0.000 description 189
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 151
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 134
239000011541 reaction mixture Substances 0.000 description 125
235000019439 ethyl acetate Nutrition 0.000 description 122
230000002829 reductive effect Effects 0.000 description 113
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 106
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 100
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 91
239000012074 organic phase Substances 0.000 description 86
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 84
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 82
239000000047 product Substances 0.000 description 82
229910052938 sodium sulfate Inorganic materials 0.000 description 80
235000011152 sodium sulphate Nutrition 0.000 description 80
238000006243 chemical reaction Methods 0.000 description 79
239000012043 crude product Substances 0.000 description 75
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 70
238000004440 column chromatography Methods 0.000 description 68
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 62
239000002904 solvent Substances 0.000 description 59
239000007832 Na2SO4 Substances 0.000 description 57
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 55
125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 52
150000003254 radicals Chemical class 0.000 description 50
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 49
239000007787 solid Substances 0.000 description 47
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 44
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 42
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 40
239000011780 sodium chloride Substances 0.000 description 39
239000008346 aqueous phase Substances 0.000 description 37
239000000741 silica gel Substances 0.000 description 35
229910002027 silica gel Inorganic materials 0.000 description 35
238000004809 thin layer chromatography Methods 0.000 description 35
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 32
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 32
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 29
150000001412 amines Chemical class 0.000 description 29
108020003175 receptors Proteins 0.000 description 29
102000005962 receptors Human genes 0.000 description 29
238000003786 synthesis reaction Methods 0.000 description 29
229960000583 acetic acid Drugs 0.000 description 28
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 27
230000015572 biosynthetic process Effects 0.000 description 27
235000011054 acetic acid Nutrition 0.000 description 26
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 25
239000012071 phase Substances 0.000 description 25
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 24
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 22
239000000725 suspension Substances 0.000 description 22
WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 21
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
238000007792 addition Methods 0.000 description 20
229910000104 sodium hydride Inorganic materials 0.000 description 19
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 18
210000004027 cell Anatomy 0.000 description 18
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 18
241000700159 Rattus Species 0.000 description 16
239000000706 filtrate Substances 0.000 description 16
229910052943 magnesium sulfate Inorganic materials 0.000 description 16
235000019341 magnesium sulphate Nutrition 0.000 description 16
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 15
239000000126 substance Substances 0.000 description 14
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 13
238000012544 monitoring process Methods 0.000 description 13
235000017557 sodium bicarbonate Nutrition 0.000 description 13
229910000030 sodium bicarbonate Inorganic materials 0.000 description 13
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
238000000746 purification Methods 0.000 description 12
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
239000002253 acid Substances 0.000 description 11
239000007789 gas Substances 0.000 description 11
238000003756 stirring Methods 0.000 description 11
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 10
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 10
DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 10
LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 9
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
230000007935 neutral effect Effects 0.000 description 9
229910000027 potassium carbonate Inorganic materials 0.000 description 9
VFHUJFBEFDVZPJ-UHFFFAOYSA-N 1h-indole-2-carboxamide Chemical class C1=CC=C2NC(C(=O)N)=CC2=C1 VFHUJFBEFDVZPJ-UHFFFAOYSA-N 0.000 description 8
GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 8
HGEWJIMSAPUWAK-UHFFFAOYSA-N 3-[4-(2-pyrrolidin-1-ylethoxy)piperidin-4-yl]pyridine;dihydrochloride Chemical compound Cl.Cl.C1CNCCC1(C=1C=NC=CC=1)OCCN1CCCC1 HGEWJIMSAPUWAK-UHFFFAOYSA-N 0.000 description 8
101800004538 Bradykinin Proteins 0.000 description 8
QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 8
101000801643 Homo sapiens Retinal-specific phospholipid-transporting ATPase ABCA4 Proteins 0.000 description 8
102100035792 Kininogen-1 Human genes 0.000 description 8
102100033617 Retinal-specific phospholipid-transporting ATPase ABCA4 Human genes 0.000 description 8
235000019270 ammonium chloride Nutrition 0.000 description 8
QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 8
238000000605 extraction Methods 0.000 description 8
238000001914 filtration Methods 0.000 description 8
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
239000012299 nitrogen atmosphere Substances 0.000 description 8
YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical class ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 8
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 7
BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 7
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 7
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 7
230000003042 antagnostic effect Effects 0.000 description 7
238000009835 boiling Methods 0.000 description 7
239000000872 buffer Substances 0.000 description 7
PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 7
230000008878 coupling Effects 0.000 description 7
238000010168 coupling process Methods 0.000 description 7
238000005859 coupling reaction Methods 0.000 description 7
238000001035 drying Methods 0.000 description 7
239000001257 hydrogen Substances 0.000 description 7
IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 7
229910000041 hydrogen chloride Inorganic materials 0.000 description 7
239000003921 oil Substances 0.000 description 7
125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 7
229940080818 propionamide Drugs 0.000 description 7
238000010992 reflux Methods 0.000 description 7
239000012312 sodium hydride Substances 0.000 description 7
239000003643 water by type Substances 0.000 description 7
MRBFGEHILMYPTF-UHFFFAOYSA-N 1-(2-Pyrimidyl)piperazine Chemical compound C1CNCCN1C1=NC=CC=N1 MRBFGEHILMYPTF-UHFFFAOYSA-N 0.000 description 6
JJUNCIUOHIQIFD-UHFFFAOYSA-N 2-[4-(3-fluorophenyl)-4-(4-methylpiperazin-1-yl)piperidin-1-yl]-n-methylethanamine;tetrahydrochloride Chemical compound Cl.Cl.Cl.Cl.C1CN(CCNC)CCC1(C=1C=C(F)C=CC=1)N1CCN(C)CC1 JJUNCIUOHIQIFD-UHFFFAOYSA-N 0.000 description 6
PSWCIARYGITEOY-UHFFFAOYSA-N 6-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2C=CNC2=C1 PSWCIARYGITEOY-UHFFFAOYSA-N 0.000 description 6
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 6
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
241001465754 Metazoa Species 0.000 description 6
BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 6
JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 6
VCEHWDBVPZFHAG-POFDKVPJSA-N [des-Arg(9)]-bradykinin Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(O)=O)CCC1 VCEHWDBVPZFHAG-POFDKVPJSA-N 0.000 description 6
125000004429 atom Chemical group 0.000 description 6
229940092714 benzenesulfonic acid Drugs 0.000 description 6
229910052796 boron Inorganic materials 0.000 description 6
NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 6
230000005764 inhibitory process Effects 0.000 description 6
239000011777 magnesium Substances 0.000 description 6
229910052749 magnesium Inorganic materials 0.000 description 6
238000005191 phase separation Methods 0.000 description 6
235000011181 potassium carbonates Nutrition 0.000 description 6
239000002244 precipitate Substances 0.000 description 6
FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
PVAJOVPTSGUOKD-UHFFFAOYSA-N tert-butyl 2-(6-aminoindol-1-yl)acetate Chemical compound C1=C(N)C=C2N(CC(=O)OC(C)(C)C)C=CC2=C1 PVAJOVPTSGUOKD-UHFFFAOYSA-N 0.000 description 6
OQZBAQXTXNIPRA-UHFFFAOYSA-N 1-pyridin-4-ylpiperazine Chemical compound C1CNCCN1C1=CC=NC=C1 OQZBAQXTXNIPRA-UHFFFAOYSA-N 0.000 description 5
101000738546 Homo sapiens Protein PTHB1 Proteins 0.000 description 5
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 5
239000012346 acetyl chloride Substances 0.000 description 5
239000004480 active ingredient Substances 0.000 description 5
230000001154 acute effect Effects 0.000 description 5
229910021529 ammonia Inorganic materials 0.000 description 5
239000005557 antagonist Substances 0.000 description 5
238000001816 cooling Methods 0.000 description 5
102000051324 human BBS9 Human genes 0.000 description 5
DKBOXZKCEURFLC-UHFFFAOYSA-N n,n-dimethyl-4-phenylpiperidin-4-amine;dihydrochloride Chemical compound Cl.Cl.C=1C=CC=CC=1C1(N(C)C)CCNCC1 DKBOXZKCEURFLC-UHFFFAOYSA-N 0.000 description 5
NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 5
239000000377 silicon dioxide Substances 0.000 description 5
BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 5
LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical compound CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 description 5
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 4
OHUMKYGINIODOY-UHFFFAOYSA-N 1-(1-methylpiperidin-4-yl)piperazine Chemical compound C1CN(C)CCC1N1CCNCC1 OHUMKYGINIODOY-UHFFFAOYSA-N 0.000 description 4
DDCPJBRBAZXSGY-UHFFFAOYSA-N 1-[4-(3-fluorophenyl)piperidin-4-yl]-4-methylpiperazine;dihydrochloride Chemical compound Cl.Cl.C1CN(C)CCN1C1(C=2C=C(F)C=CC=2)CCNCC1 DDCPJBRBAZXSGY-UHFFFAOYSA-N 0.000 description 4
HTQWGIHCFPWKAS-UHFFFAOYSA-N 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1CNCCC11C(=O)NCN1C1=CC=CC=C1 HTQWGIHCFPWKAS-UHFFFAOYSA-N 0.000 description 4
XQWYIYUUVQLNNW-UHFFFAOYSA-N 2-(bromomethyl)-6-chlorobenzoic acid Chemical compound OC(=O)C1=C(Cl)C=CC=C1CBr XQWYIYUUVQLNNW-UHFFFAOYSA-N 0.000 description 4
ZLFPWTIKFBLPGM-UHFFFAOYSA-N 2-benzyl-2,7-diazaspiro[4.4]nonane Chemical compound C=1C=CC=CC=1CN(C1)CCC21CCNC2 ZLFPWTIKFBLPGM-UHFFFAOYSA-N 0.000 description 4
TUCRZHGAIRVWTI-UHFFFAOYSA-N 2-bromothiophene Chemical compound BrC1=CC=CS1 TUCRZHGAIRVWTI-UHFFFAOYSA-N 0.000 description 4
XJKFIBMPFSXMBD-UHFFFAOYSA-N 3-(4-ethylpiperazin-1-yl)propan-1-amine Chemical compound CCN1CCN(CCCN)CC1 XJKFIBMPFSXMBD-UHFFFAOYSA-N 0.000 description 4
LLCRHLSCWWMNEC-UHFFFAOYSA-N 4-(2-pyrrolidin-1-ylethyl)piperidine Chemical compound C1CNCCC1CCN1CCCC1 LLCRHLSCWWMNEC-UHFFFAOYSA-N 0.000 description 4
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
XGAFCCUNHIMIRV-UHFFFAOYSA-N 4-chloropyridine;hydron;chloride Chemical compound Cl.ClC1=CC=NC=C1 XGAFCCUNHIMIRV-UHFFFAOYSA-N 0.000 description 4
HWJSDKNFWQDVIG-UHFFFAOYSA-N 4-pyrrolidin-3-ylpyridine Chemical compound C1NCCC1C1=CC=NC=C1 HWJSDKNFWQDVIG-UHFFFAOYSA-N 0.000 description 4
PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 4
101710134516 Des-Arg9-bradykinin Proteins 0.000 description 4
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
OUVXYXNWSVIOSJ-UHFFFAOYSA-N Fluo-4 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=C(C=2)C2=C3C=C(F)C(=O)C=C3OC3=CC(O)=C(F)C=C32)N(CC(O)=O)CC(O)=O)=C1 OUVXYXNWSVIOSJ-UHFFFAOYSA-N 0.000 description 4
WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 4
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
IHTYTYHXCRAMAV-UHFFFAOYSA-N acetic acid;dihydrochloride Chemical compound Cl.Cl.CC(O)=O IHTYTYHXCRAMAV-UHFFFAOYSA-N 0.000 description 4
230000004913 activation Effects 0.000 description 4
150000001408 amides Chemical class 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
238000003556 assay Methods 0.000 description 4
QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 4
FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 4
229910052799 carbon Inorganic materials 0.000 description 4
150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
235000019253 formic acid Nutrition 0.000 description 4
238000007429 general method Methods 0.000 description 4
AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 4
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
YJRGRZJKGMBHIB-UHFFFAOYSA-N n,n-dimethyl-3-piperazin-1-ylpropan-1-amine Chemical compound CN(C)CCCN1CCNCC1 YJRGRZJKGMBHIB-UHFFFAOYSA-N 0.000 description 4
230000002981 neuropathic effect Effects 0.000 description 4
229910052763 palladium Inorganic materials 0.000 description 4
VYSFCBZMPSKWOF-UHFFFAOYSA-N piperazin-1-yl(pyridin-3-yl)methanone Chemical compound C=1C=CN=CC=1C(=O)N1CCNCC1 VYSFCBZMPSKWOF-UHFFFAOYSA-N 0.000 description 4
239000012321 sodium triacetoxyborohydride Substances 0.000 description 4
COVRYKGBHLVHIR-UHFFFAOYSA-N tert-butyl 4-cyano-4-(dimethylamino)piperidine-1-carboxylate Chemical compound CN(C)C1(C#N)CCN(C(=O)OC(C)(C)C)CC1 COVRYKGBHLVHIR-UHFFFAOYSA-N 0.000 description 4
230000009278 visceral effect Effects 0.000 description 4
238000005406 washing Methods 0.000 description 4
AVJKDKWRVSSJPK-UHFFFAOYSA-N 1-(4-fluorophenyl)piperazine Chemical compound C1=CC(F)=CC=C1N1CCNCC1 AVJKDKWRVSSJPK-UHFFFAOYSA-N 0.000 description 3
ZXINKXGHIZTUQX-UHFFFAOYSA-N 1-(pyridin-2-ylmethyl)-1,4-diazepane Chemical compound C=1C=CC=NC=1CN1CCCNCC1 ZXINKXGHIZTUQX-UHFFFAOYSA-N 0.000 description 3
ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 3
PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 3
VGEQUMWEQWWIJT-UHFFFAOYSA-N 1-[(1-methylpiperidin-4-yl)methyl]piperazine Chemical compound C1CN(C)CCC1CN1CCNCC1 VGEQUMWEQWWIJT-UHFFFAOYSA-N 0.000 description 3
MRYYJGQKVGZGSB-UHFFFAOYSA-N 1-methyl-4-piperidin-4-ylpiperazine Chemical compound C1CN(C)CCN1C1CCNCC1 MRYYJGQKVGZGSB-UHFFFAOYSA-N 0.000 description 3
125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 3
YIMBYMVSBQILFO-UHFFFAOYSA-N 1-pyridin-4-ylpiperidin-4-amine;dihydrochloride Chemical compound Cl.Cl.C1CC(N)CCN1C1=CC=NC=C1 YIMBYMVSBQILFO-UHFFFAOYSA-N 0.000 description 3
VMTJZIDJLROXNO-UHFFFAOYSA-N 2-[(4-fluorophenyl)methyl]-2,5-diazabicyclo[2.2.1]heptane;dihydrochloride Chemical compound Cl.Cl.C1=CC(F)=CC=C1CN1C(CN2)CC2C1 VMTJZIDJLROXNO-UHFFFAOYSA-N 0.000 description 3
POHLTYPFJNZVJY-UHFFFAOYSA-N 2-[(4-fluorophenyl)methyl]-2,8-diazaspiro[4.5]decan-1-one;hydrochloride Chemical compound Cl.C1=CC(F)=CC=C1CN1C(=O)C2(CCNCC2)CC1 POHLTYPFJNZVJY-UHFFFAOYSA-N 0.000 description 3
125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 3
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
MLWKNNMSRBKBGK-UHFFFAOYSA-N 8-pyridin-4-yl-2,8-diazaspiro[4.5]decane;dihydrochloride Chemical compound Cl.Cl.C1NCCC21CCN(C=1C=CN=CC=1)CC2 MLWKNNMSRBKBGK-UHFFFAOYSA-N 0.000 description 3
MXRNVJZAZZJVQX-UHFFFAOYSA-N 9-(azetidin-1-yl)-3-azaspiro[5.5]undecane;dihydrochloride Chemical compound Cl.Cl.C1CCN1C1CCC2(CCNCC2)CC1 MXRNVJZAZZJVQX-UHFFFAOYSA-N 0.000 description 3
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 3
OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 3
239000007818 Grignard reagent Substances 0.000 description 3
239000007821 HATU Substances 0.000 description 3
239000012981 Hank's balanced salt solution Substances 0.000 description 3
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
235000011114 ammonium hydroxide Nutrition 0.000 description 3
239000002585 base Substances 0.000 description 3
230000003197 catalytic effect Effects 0.000 description 3
235000015165 citric acid Nutrition 0.000 description 3
OAOPDYUHWPBJCW-UHFFFAOYSA-N cyanoboron;sodium Chemical compound [Na].[B]C#N OAOPDYUHWPBJCW-UHFFFAOYSA-N 0.000 description 3
IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 3
239000000975 dye Substances 0.000 description 3
150000002148 esters Chemical class 0.000 description 3
150000004795 grignard reagents Chemical class 0.000 description 3
238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 3
125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
125000000593 indol-1-yl group Chemical group [H]C1=C([H])C([H])=C2N([*])C([H])=C([H])C2=C1[H] 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
239000011630 iodine Substances 0.000 description 3
INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
238000005259 measurement Methods 0.000 description 3
AXSGLXPTNSLYNN-UHFFFAOYSA-N methyl 3-(7-aminoindol-1-yl)propanoate Chemical compound C1=CC(N)=C2N(CCC(=O)OC)C=CC2=C1 AXSGLXPTNSLYNN-UHFFFAOYSA-N 0.000 description 3
201000006417 multiple sclerosis Diseases 0.000 description 3
CZPSILGHDHXWLL-UHFFFAOYSA-N n,n-dimethyl-4-thiophen-2-ylpiperidin-4-amine;dihydrochloride Chemical compound Cl.Cl.C=1C=CSC=1C1(N(C)C)CCNCC1 CZPSILGHDHXWLL-UHFFFAOYSA-N 0.000 description 3
125000001715 oxadiazolyl group Chemical group 0.000 description 3
125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
BCIIMDOZSUCSEN-UHFFFAOYSA-N piperidin-4-amine Chemical compound NC1CCNCC1 BCIIMDOZSUCSEN-UHFFFAOYSA-N 0.000 description 3
235000015320 potassium carbonate Nutrition 0.000 description 3
LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 3
230000008569 process Effects 0.000 description 3
125000006239 protecting group Chemical group 0.000 description 3
229930195734 saturated hydrocarbon Natural products 0.000 description 3
229910000029 sodium carbonate Inorganic materials 0.000 description 3
235000017550 sodium carbonate Nutrition 0.000 description 3
238000006467 substitution reaction Methods 0.000 description 3
XZFUMCMEJVJAIA-UHFFFAOYSA-N tert-butyl 2-(6-nitroindol-1-yl)acetate Chemical compound C1=C([N+]([O-])=O)C=C2N(CC(=O)OC(C)(C)C)C=CC2=C1 XZFUMCMEJVJAIA-UHFFFAOYSA-N 0.000 description 3
ROUYFJUVMYHXFJ-UHFFFAOYSA-N tert-butyl 4-oxopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=O)CC1 ROUYFJUVMYHXFJ-UHFFFAOYSA-N 0.000 description 3
JBAKABOTZNERRZ-UHFFFAOYSA-N tert-butyl n-methyl-n-(3-oxopropyl)carbamate Chemical compound O=CCCN(C)C(=O)OC(C)(C)C JBAKABOTZNERRZ-UHFFFAOYSA-N 0.000 description 3
DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 3
RXDOJDYMUFZQEE-UHFFFAOYSA-N (1-pyridin-4-ylpiperidin-4-yl)methanamine;dihydrochloride Chemical compound Cl.Cl.C1CC(CN)CCN1C1=CC=NC=C1 RXDOJDYMUFZQEE-UHFFFAOYSA-N 0.000 description 2
MDPQIKOFLZQPLB-TWGQIWQCSA-N (4Z)-N-hydroxypyridine-4-carboximidoyl chloride Chemical compound O\N=C(/Cl)C1=CC=NC=C1 MDPQIKOFLZQPLB-TWGQIWQCSA-N 0.000 description 2
PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 2
BYZGXEGZFLNLMO-UHFFFAOYSA-N 1-(2-aminoethyl)-n,n-dimethyl-4-thiophen-2-ylpiperidin-4-amine;trihydrochloride Chemical compound Cl.Cl.Cl.C=1C=CSC=1C1(N(C)C)CCN(CCN)CC1 BYZGXEGZFLNLMO-UHFFFAOYSA-N 0.000 description 2
HHVOXWSYIFASSV-UHFFFAOYSA-N 1-benzyl-4-(dimethylamino)piperidine-4-carbonitrile Chemical compound C1CC(N(C)C)(C#N)CCN1CC1=CC=CC=C1 HHVOXWSYIFASSV-UHFFFAOYSA-N 0.000 description 2
SJZKULRDWHPHGG-UHFFFAOYSA-N 1-benzylpiperidin-4-one Chemical compound C1CC(=O)CCN1CC1=CC=CC=C1 SJZKULRDWHPHGG-UHFFFAOYSA-N 0.000 description 2
FASXOHGQDHVDAD-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine;propanoic acid Chemical compound CCC(O)=O.C1CCCCN2CCCN=C21 FASXOHGQDHVDAD-UHFFFAOYSA-N 0.000 description 2
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
GLDQLMMHFMCDKQ-UHFFFAOYSA-N 2-[6-(4-methyl-3-oxo-1h-isoindol-2-yl)indol-1-yl]acetic acid Chemical compound C1=C2C=CN(CC(O)=O)C2=CC(N2CC=3C=CC=C(C=3C2=O)C)=C1 GLDQLMMHFMCDKQ-UHFFFAOYSA-N 0.000 description 2
ZAKUBZMGHXAZQA-UHFFFAOYSA-N 2-[7-(aminomethyl)indol-1-yl]-1-(9-pyridin-4-yl-3,9-diazaspiro[5.5]undecan-3-yl)ethanone Chemical compound C1=2C(CN)=CC=CC=2C=CN1CC(=O)N(CC1)CCC1(CC1)CCN1C1=CC=NC=C1 ZAKUBZMGHXAZQA-UHFFFAOYSA-N 0.000 description 2
QXGHKTYJXAJWNZ-UHFFFAOYSA-N 2-[7-(aminomethyl)indol-1-yl]acetic acid Chemical compound NCC1=CC=CC2=C1N(CC(O)=O)C=C2 QXGHKTYJXAJWNZ-UHFFFAOYSA-N 0.000 description 2
PMDMCRBFAJRCKY-UHFFFAOYSA-N 2-[7-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]indol-1-yl]acetic acid Chemical compound CC(C)(C)OC(=O)NCC1=CC=CC2=C1N(CC(O)=O)C=C2 PMDMCRBFAJRCKY-UHFFFAOYSA-N 0.000 description 2
UAUSRNCACZHLHH-UHFFFAOYSA-N 2-benzyl-2,8-diazaspiro[4.5]decan-1-one;hydrochloride Chemical compound Cl.C1CC2(CCNCC2)C(=O)N1CC1=CC=CC=C1 UAUSRNCACZHLHH-UHFFFAOYSA-N 0.000 description 2
ABFPKTQEQNICFT-UHFFFAOYSA-M 2-chloro-1-methylpyridin-1-ium;iodide Chemical compound [I-].C[N+]1=CC=CC=C1Cl ABFPKTQEQNICFT-UHFFFAOYSA-M 0.000 description 2
NYPYPOZNGOXYSU-UHFFFAOYSA-N 3-bromopyridine Chemical compound BrC1=CC=CN=C1 NYPYPOZNGOXYSU-UHFFFAOYSA-N 0.000 description 2
UURPZDUBVYSYRO-UHFFFAOYSA-N 3-pyridin-4-yl-3,9-diazaspiro[5.5]undecane Chemical compound C1CNCCC21CCN(C=1C=CN=CC=1)CC2 UURPZDUBVYSYRO-UHFFFAOYSA-N 0.000 description 2
AOFATHXSHLUUAN-UHFFFAOYSA-N 4-(4-fluorophenyl)-2-methyl-2,8-diazaspiro[4.5]decan-1-one;hydrochloride Chemical compound Cl.C1CNCCC21C(=O)N(C)CC2C1=CC=C(F)C=C1 AOFATHXSHLUUAN-UHFFFAOYSA-N 0.000 description 2
YFBVSAHYUBIHNI-UHFFFAOYSA-N 4-(azetidin-1-yl)-4-phenylcyclohexan-1-amine dihydrochloride Chemical compound Cl.Cl.C1CC(N)CCC1(C=1C=CC=CC=1)N1CCC1 YFBVSAHYUBIHNI-UHFFFAOYSA-N 0.000 description 2
BUJRWALNQXWLLK-UHFFFAOYSA-N 4-pyridin-2-ylpiperidin-4-ol Chemical compound C=1C=CC=NC=1C1(O)CCNCC1 BUJRWALNQXWLLK-UHFFFAOYSA-N 0.000 description 2
VVJAZRLYMFLGML-UHFFFAOYSA-N 4-pyridin-3-ylpiperidin-4-ol Chemical compound C=1C=CN=CC=1C1(O)CCNCC1 VVJAZRLYMFLGML-UHFFFAOYSA-N 0.000 description 2
LFWLUDLUCDRDAF-UHFFFAOYSA-N 5-methyl-1h-pyrrole-2-carbaldehyde Chemical compound CC1=CC=C(C=O)N1 LFWLUDLUCDRDAF-UHFFFAOYSA-N 0.000 description 2
HPFUEHUSRRYPNE-UHFFFAOYSA-N 7-chloro-2-[1-[3-oxo-3-(9-pyridin-4-yl-3,9-diazaspiro[5.5]undecan-3-yl)propyl]indol-6-yl]-3h-isoindol-1-one Chemical compound O=C1C=2C(Cl)=CC=CC=2CN1C(C=C12)=CC=C1C=CN2CCC(=O)N(CC1)CCC1(CC1)CCN1C1=CC=NC=C1 HPFUEHUSRRYPNE-UHFFFAOYSA-N 0.000 description 2
MVEOHWRUBFWKJY-UHFFFAOYSA-N 7-hydroxynaphthalene-2-sulfonic acid Chemical compound C1=CC(S(O)(=O)=O)=CC2=CC(O)=CC=C21 MVEOHWRUBFWKJY-UHFFFAOYSA-N 0.000 description 2
LZJGQIVWUKFTRD-UHFFFAOYSA-N 7-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=CC2=C1NC=C2 LZJGQIVWUKFTRD-UHFFFAOYSA-N 0.000 description 2
JNVWQHJNDBJJGP-UHFFFAOYSA-N 9-pyridin-4-yloxy-3-azaspiro[5.5]undecane Chemical compound C1CNCCC21CCC(OC=1C=CN=CC=1)CC2 JNVWQHJNDBJJGP-UHFFFAOYSA-N 0.000 description 2
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
208000035143 Bacterial infection Diseases 0.000 description 2
239000004342 Benzoyl peroxide Substances 0.000 description 2
GLCCMGCAEAFPNO-UHFFFAOYSA-N Cl.Cl.Cl.C1NCCC2=CC=CC=C12 Chemical compound Cl.Cl.Cl.C1NCCC2=CC=CC=C12 GLCCMGCAEAFPNO-UHFFFAOYSA-N 0.000 description 2
206010009900 Colitis ulcerative Diseases 0.000 description 2
208000011231 Crohn disease Diseases 0.000 description 2
201000003883 Cystic fibrosis Diseases 0.000 description 2
206010012438 Dermatitis atopic Diseases 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
239000001828 Gelatine Substances 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
239000007995 HEPES buffer Substances 0.000 description 2
241000282412 Homo Species 0.000 description 2
206010020751 Hypersensitivity Diseases 0.000 description 2
108010002352 Interleukin-1 Proteins 0.000 description 2
102000000589 Interleukin-1 Human genes 0.000 description 2
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 2
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
201000004681 Psoriasis Diseases 0.000 description 2
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
101150090155 R gene Proteins 0.000 description 2
NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
239000012317 TBTU Substances 0.000 description 2
102000009270 Tumour necrosis factor alpha Human genes 0.000 description 2
108050000101 Tumour necrosis factor alpha Proteins 0.000 description 2
201000006704 Ulcerative Colitis Diseases 0.000 description 2
ZUSWDTWYONAOPH-UHFFFAOYSA-N [2-(trifluoromethyl)phenyl]hydrazine;hydrochloride Chemical group [Cl-].[NH3+]NC1=CC=CC=C1C(F)(F)F ZUSWDTWYONAOPH-UHFFFAOYSA-N 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
125000002015 acyclic group Chemical group 0.000 description 2
239000000654 additive Substances 0.000 description 2
230000001270 agonistic effect Effects 0.000 description 2
230000007815 allergy Effects 0.000 description 2
239000000908 ammonium hydroxide Substances 0.000 description 2
229910052786 argon Inorganic materials 0.000 description 2
150000005840 aryl radicals Chemical class 0.000 description 2
208000006673 asthma Diseases 0.000 description 2
239000012298 atmosphere Substances 0.000 description 2
201000008937 atopic dermatitis Diseases 0.000 description 2
SJSWRKNSCWKNIR-UHFFFAOYSA-N azane;dihydrochloride Chemical compound N.Cl.Cl SJSWRKNSCWKNIR-UHFFFAOYSA-N 0.000 description 2
208000022362 bacterial infectious disease Diseases 0.000 description 2
OWCDMRFUFMERMZ-UHFFFAOYSA-N benzenesulfonamide;hydrochloride Chemical compound Cl.NS(=O)(=O)C1=CC=CC=C1 OWCDMRFUFMERMZ-UHFFFAOYSA-N 0.000 description 2
235000019400 benzoyl peroxide Nutrition 0.000 description 2
ICGXIHNNQZEWLP-UHFFFAOYSA-N benzyl 4-(dimethylamino)-4-phenylpiperidine-1-carboxylate Chemical compound C1CC(N(C)C)(C=2C=CC=CC=2)CCN1C(=O)OCC1=CC=CC=C1 ICGXIHNNQZEWLP-UHFFFAOYSA-N 0.000 description 2
ZJQMLJFHCKTCSF-UHFFFAOYSA-N benzyl 4-formylpiperidine-1-carboxylate Chemical compound C1CC(C=O)CCN1C(=O)OCC1=CC=CC=C1 ZJQMLJFHCKTCSF-UHFFFAOYSA-N 0.000 description 2
HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 2
ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
229910000024 caesium carbonate Inorganic materials 0.000 description 2
239000002775 capsule Substances 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 2
238000007865 diluting Methods 0.000 description 2
XHFGWHUWQXTGAT-UHFFFAOYSA-N dimethylamine hydrochloride Natural products CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000003480 eluent Substances 0.000 description 2
VGDUQCDAGWCFCT-UHFFFAOYSA-N ethyl 2-(6-nitroindol-1-yl)acetate Chemical compound C1=C([N+]([O-])=O)C=C2N(CC(=O)OCC)C=CC2=C1 VGDUQCDAGWCFCT-UHFFFAOYSA-N 0.000 description 2
IDAUXDVSWDYJEQ-UHFFFAOYSA-N ethyl 2-(7-cyanoindol-1-yl)acetate Chemical compound C1=CC(C#N)=C2N(CC(=O)OCC)C=CC2=C1 IDAUXDVSWDYJEQ-UHFFFAOYSA-N 0.000 description 2
PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 2
238000012632 fluorescent imaging Methods 0.000 description 2
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
239000012458 free base Substances 0.000 description 2
235000011389 fruit/vegetable juice Nutrition 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
239000008103 glucose Substances 0.000 description 2
239000008187 granular material Substances 0.000 description 2
210000003714 granulocyte Anatomy 0.000 description 2
238000000099 in vitro assay Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
230000006698 induction Effects 0.000 description 2
208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
150000007529 inorganic bases Chemical class 0.000 description 2
238000011835 investigation Methods 0.000 description 2
JXDYKVIHCLTXOP-UHFFFAOYSA-N isatin Chemical compound C1=CC=C2C(=O)C(=O)NC2=C1 JXDYKVIHCLTXOP-UHFFFAOYSA-N 0.000 description 2
125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
210000002540 macrophage Anatomy 0.000 description 2
DTKMKZYEOXZPQZ-UHFFFAOYSA-M magnesium;fluorobenzene;bromide Chemical compound [Mg+2].[Br-].FC1=CC=C[C-]=C1 DTKMKZYEOXZPQZ-UHFFFAOYSA-M 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
XJMULMWDHLJUKP-UHFFFAOYSA-N methyl 2,6-dimethylbenzoate Chemical compound COC(=O)C1=C(C)C=CC=C1C XJMULMWDHLJUKP-UHFFFAOYSA-N 0.000 description 2
UDNSKBMNXZVXKW-UHFFFAOYSA-N methyl 2-(bromomethyl)-6-methylbenzoate Chemical compound COC(=O)C1=C(C)C=CC=C1CBr UDNSKBMNXZVXKW-UHFFFAOYSA-N 0.000 description 2
239000002480 mineral oil Substances 0.000 description 2
235000010446 mineral oil Nutrition 0.000 description 2
239000003068 molecular probe Substances 0.000 description 2
210000004400 mucous membrane Anatomy 0.000 description 2
208000010125 myocardial infarction Diseases 0.000 description 2
LZJCNZXEVTXKSL-UHFFFAOYSA-N n,n-dimethyl-4-phenylpiperidin-4-amine Chemical compound C=1C=CC=CC=1C1(N(C)C)CCNCC1 LZJCNZXEVTXKSL-UHFFFAOYSA-N 0.000 description 2
LADGLPXYBPWSHC-UHFFFAOYSA-N n,n-dimethyl-4-thiophen-2-ylpiperidin-4-amine Chemical compound C=1C=CSC=1C1(N(C)C)CCNCC1 LADGLPXYBPWSHC-UHFFFAOYSA-N 0.000 description 2
DASJFYAPNPUBGG-UHFFFAOYSA-N naphthalene-1-sulfonyl chloride Chemical compound C1=CC=C2C(S(=O)(=O)Cl)=CC=CC2=C1 DASJFYAPNPUBGG-UHFFFAOYSA-N 0.000 description 2
230000004770 neurodegeneration Effects 0.000 description 2
150000007530 organic bases Chemical class 0.000 description 2
201000008482 osteoarthritis Diseases 0.000 description 2
125000002971 oxazolyl group Chemical group 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 2
DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 2
229960003081 probenecid Drugs 0.000 description 2
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
RJLCIACWXJHILW-UHFFFAOYSA-N pyridine-4-carboxamide;dihydrochloride Chemical compound Cl.Cl.NC(=O)C1=CC=NC=C1 RJLCIACWXJHILW-UHFFFAOYSA-N 0.000 description 2
125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 2
125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 2
JWEQRJSCTFBRSI-PCLIKHOPSA-N rboxylate Chemical compound COC(=O)C1C(N2C3=O)C4=CC=CC=C4OC1(C)N=C2S\C3=C\C(C=1)=CC=C(OC)C=1COC1=CC=CC=C1C JWEQRJSCTFBRSI-PCLIKHOPSA-N 0.000 description 2
206010039073 rheumatoid arthritis Diseases 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
239000011734 sodium Substances 0.000 description 2
235000009518 sodium iodide Nutrition 0.000 description 2
239000007921 spray Substances 0.000 description 2
KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
230000001629 suppression Effects 0.000 description 2
239000003826 tablet Substances 0.000 description 2
DTVYJOBDDYXAAJ-UHFFFAOYSA-N tert-butyl 2-formyl-5-methylpyrrole-1-carboxylate Chemical compound CC1=CC=C(C=O)N1C(=O)OC(C)(C)C DTVYJOBDDYXAAJ-UHFFFAOYSA-N 0.000 description 2
ICZYAUOVZLDLNK-UHFFFAOYSA-N tert-butyl 2-methyl-5-[[[1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]indol-6-yl]amino]methyl]pyrrole-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1C(C)=CC=C1CNC1=CC=C(C=CN2CC(=O)OC(C)(C)C)C2=C1 ICZYAUOVZLDLNK-UHFFFAOYSA-N 0.000 description 2
ACAJZVZKPGMTSC-UHFFFAOYSA-N tert-butyl 4-(dimethylamino)-4-phenylpiperidine-1-carboxylate Chemical compound C=1C=CC=CC=1C1(N(C)C)CCN(C(=O)OC(C)(C)C)CC1 ACAJZVZKPGMTSC-UHFFFAOYSA-N 0.000 description 2
PDTZMULNKGUIEJ-UHFFFAOYSA-N tert-butyl 4-methylidenepiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=C)CC1 PDTZMULNKGUIEJ-UHFFFAOYSA-N 0.000 description 2
GJGLBUZZTLPCOT-UHFFFAOYSA-N tert-butyl n-(3-hydroxypropyl)-n-methylcarbamate Chemical compound OCCCN(C)C(=O)OC(C)(C)C GJGLBUZZTLPCOT-UHFFFAOYSA-N 0.000 description 2
FOEKWOGKNLTMGX-UHFFFAOYSA-N tert-butyl n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]ethyl]carbamate Chemical compound C=1C=CSC=1C1(N(C)C)CCN(CCNC(=O)OC(C)(C)C)CC1 FOEKWOGKNLTMGX-UHFFFAOYSA-N 0.000 description 2
VZBXXQSJOQFMRO-UHFFFAOYSA-N tert-butyl n-[3-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]propyl]-n-methylcarbamate Chemical compound C=1C=CSC=1C1(N(C)C)CCN(CCCN(C)C(=O)OC(C)(C)C)CC1 VZBXXQSJOQFMRO-UHFFFAOYSA-N 0.000 description 2
HLUNSGKOHGMTRR-UHFFFAOYSA-N tert-butyl n-[3-[tert-butyl(dimethyl)silyl]oxypropyl]-n-methylcarbamate Chemical compound CC(C)(C)OC(=O)N(C)CCCO[Si](C)(C)C(C)(C)C HLUNSGKOHGMTRR-UHFFFAOYSA-N 0.000 description 2
FCWIHHLKNYLIML-UHFFFAOYSA-N tert-butyl n-[[1-[2-oxo-2-(9-pyridin-4-yl-3,9-diazaspiro[5.5]undecan-3-yl)ethyl]indol-7-yl]methyl]carbamate Chemical compound C1=2C(CNC(=O)OC(C)(C)C)=CC=CC=2C=CN1CC(=O)N(CC1)CCC1(CC1)CCN1C1=CC=NC=C1 FCWIHHLKNYLIML-UHFFFAOYSA-N 0.000 description 2
JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 2
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
230000009261 transgenic effect Effects 0.000 description 2
RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
238000001665 trituration Methods 0.000 description 2
108700026215 vpr Genes Proteins 0.000 description 2
QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
OFYLBLSSPQTTHT-VMPITWQZSA-N (NE)-N-(pyridin-4-ylmethylidene)hydroxylamine Chemical compound O\N=C\C1=CC=NC=C1 OFYLBLSSPQTTHT-VMPITWQZSA-N 0.000 description 1
APQIUTYORBAGEZ-UHFFFAOYSA-N 1,1-dibromoethane Chemical compound CC(Br)Br APQIUTYORBAGEZ-UHFFFAOYSA-N 0.000 description 1
VKRKCBWIVLSRBJ-UHFFFAOYSA-N 1,4-dioxaspiro[4.5]decan-8-one Chemical compound C1CC(=O)CCC21OCCO2 VKRKCBWIVLSRBJ-UHFFFAOYSA-N 0.000 description 1
FQUOZIAUEWQGMC-UHFFFAOYSA-N 1-(2-aminoethyl)-n,n-dimethyl-4-thiophen-2-ylpiperidin-4-amine Chemical compound C=1C=CSC=1C1(N(C)C)CCN(CCN)CC1 FQUOZIAUEWQGMC-UHFFFAOYSA-N 0.000 description 1
RMGFLMXDCGQKPS-UHFFFAOYSA-N 1-(2-chloroethyl)pyrrolidine Chemical compound ClCCN1CCCC1 RMGFLMXDCGQKPS-UHFFFAOYSA-N 0.000 description 1
ZBMWKKZUPQVEJV-UHFFFAOYSA-N 1-[4-(3-fluorophenyl)piperidin-4-yl]-4-methylpiperazine Chemical compound C1CN(C)CCN1C1(C=2C=C(F)C=CC=2)CCNCC1 ZBMWKKZUPQVEJV-UHFFFAOYSA-N 0.000 description 1
LDUXAULZICUOCV-UHFFFAOYSA-N 1-benzyl-4-pyridin-3-ylpiperidin-4-ol Chemical compound C1CC(O)(C=2C=NC=CC=2)CCN1CC1=CC=CC=C1 LDUXAULZICUOCV-UHFFFAOYSA-N 0.000 description 1
UPCGCKVYJLDAKD-UHFFFAOYSA-N 1-benzyl-n,n-dimethyl-4-phenylpiperidin-4-amine Chemical compound C1CC(N(C)C)(C=2C=CC=CC=2)CCN1CC1=CC=CC=C1 UPCGCKVYJLDAKD-UHFFFAOYSA-N 0.000 description 1
MLEGMEBCXGDFQT-UHFFFAOYSA-N 1-benzylpiperidin-2-one Chemical compound O=C1CCCCN1CC1=CC=CC=C1 MLEGMEBCXGDFQT-UHFFFAOYSA-N 0.000 description 1
RBAHXNSORRGCQA-UHFFFAOYSA-N 1-chloro-2-fluoro-3-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(Cl)=C1F RBAHXNSORRGCQA-UHFFFAOYSA-N 0.000 description 1
PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 1
JCHJBEZBHANKGA-UHFFFAOYSA-N 1-methoxy-3,5-dimethylbenzene Chemical compound COC1=CC(C)=CC(C)=C1 JCHJBEZBHANKGA-UHFFFAOYSA-N 0.000 description 1
125000004484 1-methylpiperidin-4-yl group Chemical group CN1CCC(CC1)* 0.000 description 1
SLMXUTJFULFSMQ-UHFFFAOYSA-N 1-o-benzyl 4-o-methyl piperidine-1,4-dicarboxylate Chemical compound C1CC(C(=O)OC)CCN1C(=O)OCC1=CC=CC=C1 SLMXUTJFULFSMQ-UHFFFAOYSA-N 0.000 description 1
URTPNQRAHXRPMP-UHFFFAOYSA-N 1-phenylmethoxycarbonylpiperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C(=O)OCC1=CC=CC=C1 URTPNQRAHXRPMP-UHFFFAOYSA-N 0.000 description 1
BTDZSVPICJLNIN-UHFFFAOYSA-N 1-pyridin-4-ylpiperidin-4-amine Chemical compound C1CC(N)CCN1C1=CC=NC=C1 BTDZSVPICJLNIN-UHFFFAOYSA-N 0.000 description 1
125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
IHWDSEPNZDYMNF-UHFFFAOYSA-N 1H-indol-2-amine Chemical class C1=CC=C2NC(N)=CC2=C1 IHWDSEPNZDYMNF-UHFFFAOYSA-N 0.000 description 1
NTUHBYLZRBVHRS-UHFFFAOYSA-N 1h-indole-7-carbonitrile Chemical compound N#CC1=CC=CC2=C1NC=C2 NTUHBYLZRBVHRS-UHFFFAOYSA-N 0.000 description 1
OXBLVCZKDOZZOJ-UHFFFAOYSA-N 2,3-Dihydrothiophene Chemical compound C1CC=CS1 OXBLVCZKDOZZOJ-UHFFFAOYSA-N 0.000 description 1
FFFIRKXTFQCCKJ-UHFFFAOYSA-N 2,4,6-trimethylbenzoic acid Chemical compound CC1=CC(C)=C(C(O)=O)C(C)=C1 FFFIRKXTFQCCKJ-UHFFFAOYSA-N 0.000 description 1
125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 1
HCBHQDKBSKYGCK-UHFFFAOYSA-N 2,6-dimethylbenzoic acid Chemical compound CC1=CC=CC(C)=C1C(O)=O HCBHQDKBSKYGCK-UHFFFAOYSA-N 0.000 description 1
WYQDNCSQKCETCI-UHFFFAOYSA-N 2-(1-pyridin-4-ylpiperidin-4-yl)ethanamine;dihydrochloride Chemical compound Cl.Cl.C1CC(CCN)CCN1C1=CC=NC=C1 WYQDNCSQKCETCI-UHFFFAOYSA-N 0.000 description 1
ZQVHJNFSVNKKAM-UHFFFAOYSA-N 2-(4-fluorophenyl)-2,8-diazaspiro[4.5]decan-1-one Chemical compound C1=CC(F)=CC=C1N1C(=O)C2(CCNCC2)CC1 ZQVHJNFSVNKKAM-UHFFFAOYSA-N 0.000 description 1
STCSNHCXFFFHKE-UHFFFAOYSA-N 2-(4-fluorophenyl)-2,8-diazaspiro[4.5]decan-1-one;hydrochloride Chemical compound Cl.C1=CC(F)=CC=C1N1C(=O)C2(CCNCC2)CC1 STCSNHCXFFFHKE-UHFFFAOYSA-N 0.000 description 1
DCQLWBJDOYPXDJ-UHFFFAOYSA-N 2-(7-cyanoindol-1-yl)acetic acid Chemical compound C1=CC(C#N)=C2N(CC(=O)O)C=CC2=C1 DCQLWBJDOYPXDJ-UHFFFAOYSA-N 0.000 description 1
FTZFWXXOVFUOJS-UHFFFAOYSA-N 2-(pyridin-4-ylmethyl)-2,5-diazabicyclo[2.2.1]heptane;dihydrochloride Chemical compound Cl.Cl.C1C(NC2)CC2N1CC1=CC=NC=C1 FTZFWXXOVFUOJS-UHFFFAOYSA-N 0.000 description 1
MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical class C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 1
CUFUQVXZEVYJGA-UHFFFAOYSA-N 2-[1-[2-[9-(azetidin-1-yl)-3-azaspiro[5.5]undecan-3-yl]-2-oxoethyl]indol-6-yl]-7-chloro-3h-isoindol-1-one Chemical compound O=C1C=2C(Cl)=CC=CC=2CN1C(C=C12)=CC=C1C=CN2CC(=O)N(CC1)CCC1(CC1)CCC1N1CCC1 CUFUQVXZEVYJGA-UHFFFAOYSA-N 0.000 description 1
CDSCHOMFERMDMF-UHFFFAOYSA-N 2-[5-(8-chloro-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazin-2-yl)indol-1-yl]acetic acid Chemical compound C1CN2C=CC(Cl)=C2C(=O)N1C1=CC=C2N(CC(=O)O)C=CC2=C1 CDSCHOMFERMDMF-UHFFFAOYSA-N 0.000 description 1
MZCSYSAHQLYVIV-UHFFFAOYSA-N 2-[6-(10-chloro-1-oxo-3,4-dihydropyrazino[1,2-a]indol-2-yl)indol-1-yl]acetic acid Chemical compound O=C1C2=C(Cl)C3=CC=CC=C3N2CCN1C1=CC=C2C=CN(CC(=O)O)C2=C1 MZCSYSAHQLYVIV-UHFFFAOYSA-N 0.000 description 1
XZIGJLMCRPPLRM-UHFFFAOYSA-N 2-[6-(4-chloro-3-oxo-1h-isoindol-2-yl)indol-1-yl]-n-methyl-n-[3-(4-pyridin-4-ylpiperazin-1-yl)propyl]acetamide Chemical compound C1=CC2=CC=C(N3C(C4=C(Cl)C=CC=C4C3)=O)C=C2N1CC(=O)N(C)CCCN(CC1)CCN1C1=CC=NC=C1 XZIGJLMCRPPLRM-UHFFFAOYSA-N 0.000 description 1
QTNGXBMHAGFJAN-UHFFFAOYSA-N 2-[6-(4-chloro-3-oxo-1h-isoindol-2-yl)indol-1-yl]acetic acid Chemical compound C1C2=CC=CC(Cl)=C2C(=O)N1C1=CC=C2C=CN(CC(=O)O)C2=C1 QTNGXBMHAGFJAN-UHFFFAOYSA-N 0.000 description 1
ASDZRBASYYXYBX-UHFFFAOYSA-N 2-[6-(5-methyl-3-oxo-1h-pyrrolo[1,2-c]imidazol-2-yl)indol-1-yl]acetic acid Chemical compound C1=C2C=CN(CC(O)=O)C2=CC(N2CC3=CC=C(N3C2=O)C)=C1 ASDZRBASYYXYBX-UHFFFAOYSA-N 0.000 description 1
LKWZQOFIYSXPAC-UHFFFAOYSA-N 2-[6-(8-chloro-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazin-2-yl)indol-1-yl]acetic acid Chemical compound C1CN2C=CC(Cl)=C2C(=O)N1C1=CC=C2C=CN(CC(=O)O)C2=C1 LKWZQOFIYSXPAC-UHFFFAOYSA-N 0.000 description 1
PWLOHLOKLSBMMV-UHFFFAOYSA-N 2-[6-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]indol-1-yl]-n-[2-(1-pyridin-4-ylpiperidin-4-yl)ethyl]acetamide Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)NC=2C=C3N(CC(=O)NCCC4CCN(CC4)C=4C=CN=CC=4)C=CC3=CC=2)=C1C PWLOHLOKLSBMMV-UHFFFAOYSA-N 0.000 description 1
RJAMFYMHENSGIA-UHFFFAOYSA-N 2-[6-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]indol-1-yl]-n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]propyl]-n-methylacetamide Chemical compound C1CC(N(C)C)(C=2C=CC=CC=2)CCN1CCCN(C)C(=O)CN(C1=C2)C=CC1=CC=C2NS(=O)(=O)C1=CC(C)=C(Cl)C=C1C RJAMFYMHENSGIA-UHFFFAOYSA-N 0.000 description 1
ZBQYLMDYPWOFIJ-UHFFFAOYSA-N 2-[7-(4-chloro-3-oxo-1h-isoindol-2-yl)indol-1-yl]acetic acid Chemical compound C1C2=CC=CC(Cl)=C2C(=O)N1C1=C2N(CC(=O)O)C=CC2=CC=C1 ZBQYLMDYPWOFIJ-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
VIKBNMWOLLIQPG-UHFFFAOYSA-N 2-methyldecanedioic acid Chemical compound OC(=O)C(C)CCCCCCCC(O)=O VIKBNMWOLLIQPG-UHFFFAOYSA-N 0.000 description 1
125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
RJZDFQFHALFSGR-UHFFFAOYSA-N 2-pyridin-4-yl-2,7-diazaspiro[4.4]nonane Chemical compound C1NCCC11CN(C=2C=CN=CC=2)CC1 RJZDFQFHALFSGR-UHFFFAOYSA-N 0.000 description 1
NTKSSKJJOJPJCO-UHFFFAOYSA-N 2-pyridin-4-yl-2,7-diazaspiro[4.4]nonane;dihydrochloride Chemical compound Cl.Cl.C1NCCC11CN(C=2C=CN=CC=2)CC1 NTKSSKJJOJPJCO-UHFFFAOYSA-N 0.000 description 1
CDBAEFXTCRKJPZ-UHFFFAOYSA-N 3,3-difluoroazetidine;hydron;chloride Chemical compound Cl.FC1(F)CNC1 CDBAEFXTCRKJPZ-UHFFFAOYSA-N 0.000 description 1
125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
AJHPGXZOIAYYDW-UHFFFAOYSA-N 3-(2-cyanophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)NC(C(O)=O)CC1=CC=CC=C1C#N AJHPGXZOIAYYDW-UHFFFAOYSA-N 0.000 description 1
RAVPLFYIHBHEQF-UHFFFAOYSA-N 3-[6-(4-chloro-3-oxo-1h-isoindol-2-yl)indol-1-yl]-n-methyl-n-[3-(4-pyridin-4-ylpiperazin-1-yl)propyl]propanamide Chemical compound C1=CC2=CC=C(N3C(C4=C(Cl)C=CC=C4C3)=O)C=C2N1CCC(=O)N(C)CCCN(CC1)CCN1C1=CC=NC=C1 RAVPLFYIHBHEQF-UHFFFAOYSA-N 0.000 description 1
FSRLNEATWVPNMS-UHFFFAOYSA-N 3-[6-(4-chloro-3-oxo-1h-isoindol-2-yl)indol-1-yl]propanoic acid Chemical compound C1C2=CC=CC(Cl)=C2C(=O)N1C1=CC=C2C=CN(CCC(=O)O)C2=C1 FSRLNEATWVPNMS-UHFFFAOYSA-N 0.000 description 1
MSVIYWMCNKFEQQ-UHFFFAOYSA-N 3-[6-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]indol-1-yl]-n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]ethyl]propanamide Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1CCNC(=O)CCN(C1=C2)C=CC1=CC=C2NS(=O)(=O)C1=CC(C)=C(Cl)C=C1C MSVIYWMCNKFEQQ-UHFFFAOYSA-N 0.000 description 1
KXJJMKXYRHQKBU-UHFFFAOYSA-N 3-[6-[(4-methoxy-2,6-dimethylphenyl)sulfonylamino]indol-1-yl]-n-[2-(1-pyridin-4-ylpiperidin-4-yl)ethyl]propanamide Chemical compound CC1=CC(OC)=CC(C)=C1S(=O)(=O)NC1=CC=C(C=CN2CCC(=O)NCCC3CCN(CC3)C=3C=CN=CC=3)C2=C1 KXJJMKXYRHQKBU-UHFFFAOYSA-N 0.000 description 1
JKNLKBKFHNCHKQ-UHFFFAOYSA-N 3-[7-(4-chloro-3-oxo-1h-isoindol-2-yl)indol-1-yl]-n-[(1-pyridin-4-ylpiperidin-4-yl)methyl]propanamide Chemical compound O=C1C=2C(Cl)=CC=CC=2CN1C(C1=2)=CC=CC=2C=CN1CCC(=O)NCC(CC1)CCN1C1=CC=NC=C1 JKNLKBKFHNCHKQ-UHFFFAOYSA-N 0.000 description 1
ZOOHIGMFNYETLM-UHFFFAOYSA-N 3-[7-(4-chloro-3-oxo-1h-isoindol-2-yl)indol-1-yl]propanoic acid Chemical compound C1C2=CC=CC(Cl)=C2C(=O)N1C1=C2N(CCC(=O)O)C=CC2=CC=C1 ZOOHIGMFNYETLM-UHFFFAOYSA-N 0.000 description 1
ZAWPTSWRPFAIEI-UHFFFAOYSA-N 3-[7-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]indol-1-yl]-n-[2-(1-pyridin-4-ylpiperidin-4-yl)ethyl]propanamide Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)NC=2C=3N(CCC(=O)NCCC4CCN(CC4)C=4C=CN=CC=4)C=CC=3C=CC=2)=C1C ZAWPTSWRPFAIEI-UHFFFAOYSA-N 0.000 description 1
GNHWRUGXXOUMEX-UHFFFAOYSA-N 3-[7-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]indol-1-yl]-n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]ethyl]propanamide Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1CCNC(=O)CCN(C=12)C=CC2=CC=CC=1NS(=O)(=O)C1=CC(C)=C(Cl)C=C1C GNHWRUGXXOUMEX-UHFFFAOYSA-N 0.000 description 1
PHKOEVSFOBNWKA-UHFFFAOYSA-N 3-[7-[(4-methoxy-2,6-dimethylphenyl)sulfonylamino]indol-1-yl]-n-[2-(1-pyridin-4-ylpiperidin-4-yl)ethyl]propanamide Chemical compound CC1=CC(OC)=CC(C)=C1S(=O)(=O)NC1=CC=CC2=C1N(CCC(=O)NCCC1CCN(CC1)C=1C=CN=CC=1)C=C2 PHKOEVSFOBNWKA-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
UAHSHKGOUSVRSI-UHFFFAOYSA-N 3-chloro-1H-pyrrole-2-carboxylic acid methyl 3-chloro-1H-pyrrole-2-carboxylate Chemical compound ClC1=C(NC=C1)C(=O)OC.ClC1=C(NC=C1)C(=O)O UAHSHKGOUSVRSI-UHFFFAOYSA-N 0.000 description 1
MVEQAUFZXJDLOP-UHFFFAOYSA-N 3-chloro-1h-indole-2-carboxylic acid Chemical compound C1=CC=C2C(Cl)=C(C(=O)O)NC2=C1 MVEQAUFZXJDLOP-UHFFFAOYSA-N 0.000 description 1
LFZYUOPMTOBASU-UHFFFAOYSA-N 3-chloro-1h-pyrrole-2-carboxylic acid Chemical compound OC(=O)C=1NC=CC=1Cl LFZYUOPMTOBASU-UHFFFAOYSA-N 0.000 description 1
IHPRVZKJZGXTBQ-UHFFFAOYSA-N 3-chloropropan-1-amine;hydron;chloride Chemical compound Cl.NCCCCl IHPRVZKJZGXTBQ-UHFFFAOYSA-N 0.000 description 1
HLFVADAWUOIQGN-UHFFFAOYSA-N 3-pyridin-4-yl-1-oxa-2,8-diazaspiro[4.5]dec-2-ene Chemical compound C1C(C=2C=CN=CC=2)=NOC11CCNCC1 HLFVADAWUOIQGN-UHFFFAOYSA-N 0.000 description 1
LSPVHTUVDOJTFL-UHFFFAOYSA-N 3-pyridin-4-yl-1-oxa-2,8-diazaspiro[4.5]dec-2-ene;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.C1C(C=2C=CN=CC=2)=NOC11CCNCC1 LSPVHTUVDOJTFL-UHFFFAOYSA-N 0.000 description 1
JBESTOARBDFYLC-UHFFFAOYSA-N 3-pyridin-4-yl-3,9-diazaspiro[5.5]undecane;dihydrochloride Chemical compound Cl.Cl.C1CNCCC21CCN(C=1C=CN=CC=1)CC2 JBESTOARBDFYLC-UHFFFAOYSA-N 0.000 description 1
OJENOEVLDAOQGM-UHFFFAOYSA-N 4-(azetidin-1-yl)-4-phenylcyclohexan-1-amine Chemical compound C1CC(N)CCC1(C=1C=CC=CC=1)N1CCC1 OJENOEVLDAOQGM-UHFFFAOYSA-N 0.000 description 1
XHZBGKMOECVLHH-UHFFFAOYSA-N 4-(azetidin-1-yl)-4-phenylcyclohexan-1-amine hydrochloride Chemical compound Cl.C1CC(N)CCC1(C=1C=CC=CC=1)N1CCC1 XHZBGKMOECVLHH-UHFFFAOYSA-N 0.000 description 1
URYQTQDYBURNGY-UHFFFAOYSA-N 4-(azetidin-1-yl)-4-phenylcyclohexan-1-one Chemical compound C1CC(=O)CCC1(C=1C=CC=CC=1)N1CCC1 URYQTQDYBURNGY-UHFFFAOYSA-N 0.000 description 1
ALYNCZNDIQEVRV-PZFLKRBQSA-N 4-amino-3,5-ditritiobenzoic acid Chemical compound [3H]c1cc(cc([3H])c1N)C(O)=O ALYNCZNDIQEVRV-PZFLKRBQSA-N 0.000 description 1
BSDGZUDFPKIYQG-UHFFFAOYSA-N 4-bromopyridine Chemical compound BrC1=CC=NC=C1 BSDGZUDFPKIYQG-UHFFFAOYSA-N 0.000 description 1
IEGDPHUYNPTRII-UHFFFAOYSA-N 4-chloro-2,5-dimethyl-n-[1-[3-[4-[(1-methylpiperidin-4-yl)methyl]piperazin-1-yl]-3-oxopropyl]indol-7-yl]benzenesulfonamide Chemical compound C1CN(C)CCC1CN1CCN(C(=O)CCN2C3=C(NS(=O)(=O)C=4C(=CC(Cl)=C(C)C=4)C)C=CC=C3C=C2)CC1 IEGDPHUYNPTRII-UHFFFAOYSA-N 0.000 description 1
229960000549 4-dimethylaminophenol Drugs 0.000 description 1
GCNTZFIIOFTKIY-UHFFFAOYSA-N 4-hydroxypyridine Chemical compound OC1=CC=NC=C1 GCNTZFIIOFTKIY-UHFFFAOYSA-N 0.000 description 1
SHKXGVBQMJFCCU-UHFFFAOYSA-N 4-methoxy-2,6-dimethyl-N-[1-[2-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-2-oxoethyl]indol-6-yl]benzenesulfonamide Chemical compound COc1cc(C)c(c(C)c1)S(=O)(=O)Nc1ccc2ccn(CC(=O)N3CCN(CC3)C3CCN(C)CC3)c2c1 SHKXGVBQMJFCCU-UHFFFAOYSA-N 0.000 description 1
RVGDYJKQYHUVSG-UHFFFAOYSA-N 4-methoxy-2,6-dimethyl-n-[1-[2-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-2-oxoethyl]indol-6-yl]benzenesulfonamide Chemical compound CC1=CC(OC)=CC(C)=C1S(=O)(=O)NC1=CC=C(C=CN2CC(=O)N3CCC(CC3)N3CCN(C)CC3)C2=C1 RVGDYJKQYHUVSG-UHFFFAOYSA-N 0.000 description 1
QUKWTYIQBFSLKQ-UHFFFAOYSA-N 4-methoxy-2,6-dimethyl-n-[1-[2-[4-[(1-methylpiperidin-4-yl)methyl]piperazin-1-yl]-2-oxoethyl]indol-6-yl]benzenesulfonamide Chemical compound CC1=CC(OC)=CC(C)=C1S(=O)(=O)NC1=CC=C(C=CN2CC(=O)N3CCN(CC4CCN(C)CC4)CC3)C2=C1 QUKWTYIQBFSLKQ-UHFFFAOYSA-N 0.000 description 1
NIKZUTXWGFLJCR-UHFFFAOYSA-N 4-methoxy-2,6-dimethyl-n-[1-[2-oxo-2-(4-pyrimidin-2-ylpiperazin-1-yl)ethyl]indol-7-yl]benzenesulfonamide Chemical compound CC1=CC(OC)=CC(C)=C1S(=O)(=O)NC1=CC=CC2=C1N(CC(=O)N1CCN(CC1)C=1N=CC=CN=1)C=C2 NIKZUTXWGFLJCR-UHFFFAOYSA-N 0.000 description 1
RZZRJWYQWDEXBE-UHFFFAOYSA-N 4-methoxy-2,6-dimethyl-n-[1-[2-oxo-2-(7-pyridin-4-yl-2,7-diazaspiro[4.4]nonan-2-yl)ethyl]indol-7-yl]benzenesulfonamide Chemical compound CC1=CC(OC)=CC(C)=C1S(=O)(=O)NC1=CC=CC2=C1N(CC(=O)N1CC3(CN(CC3)C=3C=CN=CC=3)CC1)C=C2 RZZRJWYQWDEXBE-UHFFFAOYSA-N 0.000 description 1
XZLCSMILTVWOPC-UHFFFAOYSA-N 4-methoxy-2,6-dimethyl-n-[1-[2-oxo-2-(8-pyridin-4-yl-2,8-diazaspiro[4.5]decan-2-yl)ethyl]indol-7-yl]benzenesulfonamide Chemical compound CC1=CC(OC)=CC(C)=C1S(=O)(=O)NC1=CC=CC2=C1N(CC(=O)N1CC3(CC1)CCN(CC3)C=1C=CN=CC=1)C=C2 XZLCSMILTVWOPC-UHFFFAOYSA-N 0.000 description 1
HMKBWCQHOHLTQB-UHFFFAOYSA-N 4-methoxy-2,6-dimethyl-n-[1-[3-[4-[(1-methylpiperidin-4-yl)methyl]piperazin-1-yl]-3-oxopropyl]indol-7-yl]benzenesulfonamide Chemical compound CC1=CC(OC)=CC(C)=C1S(=O)(=O)NC1=CC=CC2=C1N(CCC(=O)N1CCN(CC3CCN(C)CC3)CC1)C=C2 HMKBWCQHOHLTQB-UHFFFAOYSA-N 0.000 description 1
NGXRYLKBSIVHQE-UHFFFAOYSA-N 4-methoxy-2,6-dimethyl-n-[[1-[2-oxo-2-(9-pyridin-4-yl-3,9-diazaspiro[5.5]undecan-3-yl)ethyl]indol-7-yl]methyl]benzenesulfonamide Chemical compound CC1=CC(OC)=CC(C)=C1S(=O)(=O)NCC1=CC=CC2=C1N(CC(=O)N1CCC3(CC1)CCN(CC3)C=1C=CN=CC=1)C=C2 NGXRYLKBSIVHQE-UHFFFAOYSA-N 0.000 description 1
ZJJLGMUSGUYZQP-UHFFFAOYSA-N 4-methoxy-2,6-dimethylbenzenesulfonamide Chemical compound COC1=CC(C)=C(S(N)(=O)=O)C(C)=C1 ZJJLGMUSGUYZQP-UHFFFAOYSA-N 0.000 description 1
FARJAHHRGCAAOY-UHFFFAOYSA-N 4-methoxy-2,6-dimethylbenzenesulfonyl chloride Chemical compound COC1=CC(C)=C(S(Cl)(=O)=O)C(C)=C1 FARJAHHRGCAAOY-UHFFFAOYSA-N 0.000 description 1
ACEAJNDSIIYMJN-UHFFFAOYSA-N 4-methyl-1-phenylmethoxycarbonylpiperidine-4-carboxylic acid 1-phenylmethoxycarbonylpiperidine-4-carboxylic acid Chemical compound C(C1=CC=CC=C1)OC(=O)N1CCC(CC1)C(=O)O.CC1(CCN(CC1)C(=O)OCC1=CC=CC=C1)C(=O)O ACEAJNDSIIYMJN-UHFFFAOYSA-N 0.000 description 1
AKSROANEAXDUGX-UHFFFAOYSA-N 4-piperidin-4-yloxypyridine;hydrochloride Chemical compound Cl.C1CNCCC1OC1=CC=NC=C1 AKSROANEAXDUGX-UHFFFAOYSA-N 0.000 description 1
ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
VKYFSDSRYNQBGL-UHFFFAOYSA-N 6-(piperidin-1-ylmethyl)-2-pyrrolidin-3-yl-3,4-dihydro-1h-isoquinoline Chemical compound C=1C=C2CN(C3CNCC3)CCC2=CC=1CN1CCCCC1 VKYFSDSRYNQBGL-UHFFFAOYSA-N 0.000 description 1
ZAVPIHYBQNURSV-UHFFFAOYSA-N 6-(piperidin-1-ylmethyl)-2-pyrrolidin-3-yl-3,4-dihydro-1h-isoquinoline;trihydrochloride Chemical compound Cl.Cl.Cl.C=1C=C2CN(C3CNCC3)CCC2=CC=1CN1CCCCC1 ZAVPIHYBQNURSV-UHFFFAOYSA-N 0.000 description 1
QWYOKZQNUMYTOP-UHFFFAOYSA-N 7-chloro-2-[1-[2-[9-(3,3-difluoroazetidin-1-yl)-3-azaspiro[5.5]undecan-3-yl]-2-oxoethyl]indol-6-yl]-3h-isoindol-1-one Chemical compound C1C(F)(F)CN1C1CCC2(CCN(CC2)C(=O)CN2C3=CC(=CC=C3C=C2)N2C(C3=C(Cl)C=CC=C3C2)=O)CC1 QWYOKZQNUMYTOP-UHFFFAOYSA-N 0.000 description 1
PCXYQFZWXFZUDH-UHFFFAOYSA-N 7-chloro-2-[1-[2-oxo-2-(3-pyridin-4-yl-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl)ethyl]indol-6-yl]-3h-isoindol-1-one Chemical compound O=C1C=2C(Cl)=CC=CC=2CN1C(C=C12)=CC=C1C=CN2CC(=O)N(CC1)CCC1(ON=1)CC=1C1=CC=NC=C1 PCXYQFZWXFZUDH-UHFFFAOYSA-N 0.000 description 1
OAGNSOUCFDZRGB-UHFFFAOYSA-N 7-chloro-2-[1-[2-oxo-2-(8-pyridin-4-yl-2,8-diazaspiro[4.5]decan-2-yl)ethyl]indol-6-yl]-3h-isoindol-1-one Chemical compound O=C1C=2C(Cl)=CC=CC=2CN1C(C=C12)=CC=C1C=CN2CC(=O)N(C1)CCC1(CC1)CCN1C1=CC=NC=C1 OAGNSOUCFDZRGB-UHFFFAOYSA-N 0.000 description 1
DWGVZGHNVZQOHJ-UHFFFAOYSA-N 7-chloro-2-[1-[2-oxo-2-(9-pyridin-4-yloxy-3-azaspiro[5.5]undecan-3-yl)ethyl]indol-6-yl]-3h-isoindol-1-one Chemical compound O=C1C=2C(Cl)=CC=CC=2CN1C(C=C12)=CC=C1C=CN2CC(=O)N(CC1)CCC1(CC1)CCC1OC1=CC=NC=C1 DWGVZGHNVZQOHJ-UHFFFAOYSA-N 0.000 description 1
GMBFAEZMZXPAJX-UHFFFAOYSA-N 7-chloro-2-[1-[3-[4-[(1-methylpiperidin-4-yl)methyl]piperazin-1-yl]-3-oxopropyl]indol-6-yl]-3h-isoindol-1-one Chemical compound C1CN(C)CCC1CN1CCN(C(=O)CCN2C3=CC(=CC=C3C=C2)N2C(C3=C(Cl)C=CC=C3C2)=O)CC1 GMBFAEZMZXPAJX-UHFFFAOYSA-N 0.000 description 1
FOYHFKPLTNYXAP-UHFFFAOYSA-N 7-chloro-2-[1-[3-oxo-3-(4-pyridin-4-yloxypiperidin-1-yl)propyl]indol-6-yl]-3h-isoindol-1-one Chemical compound O=C1C=2C(Cl)=CC=CC=2CN1C(C=C12)=CC=C1C=CN2CCC(=O)N(CC1)CCC1OC1=CC=NC=C1 FOYHFKPLTNYXAP-UHFFFAOYSA-N 0.000 description 1
MXMQUYYGELTQFW-UHFFFAOYSA-N 7-chloro-2-[1-[3-oxo-3-(4-pyridin-4-ylpiperazin-1-yl)propyl]indol-6-yl]-3h-isoindol-1-one Chemical compound O=C1C=2C(Cl)=CC=CC=2CN1C(C=C12)=CC=C1C=CN2CCC(=O)N(CC1)CCN1C1=CC=NC=C1 MXMQUYYGELTQFW-UHFFFAOYSA-N 0.000 description 1
RSWVDKOTHOHNSR-UHFFFAOYSA-N 9-(3,3-difluoroazetidin-1-yl)-3-azaspiro[5.5]undecane Chemical compound C1C(F)(F)CN1C1CCC2(CCNCC2)CC1 RSWVDKOTHOHNSR-UHFFFAOYSA-N 0.000 description 1
DVLZDQBVKCKTGA-UHFFFAOYSA-N 9-(3,3-difluoroazetidin-1-yl)-3-azaspiro[5.5]undecane;dihydrochloride Chemical compound Cl.Cl.C1C(F)(F)CN1C1CCC2(CCNCC2)CC1 DVLZDQBVKCKTGA-UHFFFAOYSA-N 0.000 description 1
FUYBDLZOZHDLQQ-UHFFFAOYSA-N 9-pyridin-4-yloxy-3-azaspiro[5.5]undecane;dihydrochloride Chemical compound Cl.Cl.C1CNCCC21CCC(OC=1C=CN=CC=1)CC2 FUYBDLZOZHDLQQ-UHFFFAOYSA-N 0.000 description 1
102100022907 Acrosin-binding protein Human genes 0.000 description 1
208000009137 Behcet syndrome Diseases 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
RSXZQPYNCWRSAI-UHFFFAOYSA-N CC(C)(C)OC(=O)N1CCC2(CCC(O)CC2)CC1.CC(C)(C)OC(=O)N1CCC2(CC1)CCC(=O)CC2 Chemical compound CC(C)(C)OC(=O)N1CCC2(CCC(O)CC2)CC1.CC(C)(C)OC(=O)N1CCC2(CC1)CCC(=O)CC2 RSXZQPYNCWRSAI-UHFFFAOYSA-N 0.000 description 1
DFCWRARNYYXIGI-UHFFFAOYSA-N CC=1CCCN1.ClC1(CCN=C1C(Cl)(Cl)Cl)Cl Chemical compound CC=1CCCN1.ClC1(CCN=C1C(Cl)(Cl)Cl)Cl DFCWRARNYYXIGI-UHFFFAOYSA-N 0.000 description 1
101100063435 Caenorhabditis elegans din-1 gene Proteins 0.000 description 1
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
MYODDZGZTSGLGI-UHFFFAOYSA-N Cl.ClC1=CC=NC=C1.N1=CC=C(C=C1)OC1CCC2(CCN(CC2)C(=O)OC(C)(C)C)CC1 Chemical compound Cl.ClC1=CC=NC=C1.N1=CC=C(C=C1)OC1CCC2(CCN(CC2)C(=O)OC(C)(C)C)CC1 MYODDZGZTSGLGI-UHFFFAOYSA-N 0.000 description 1
RYMCJLZRYBXFAP-UHFFFAOYSA-N Cl.N1(CCC1)C1CCC2(CCNCC2)CC1 Chemical compound Cl.N1(CCC1)C1CCC2(CCNCC2)CC1 RYMCJLZRYBXFAP-UHFFFAOYSA-N 0.000 description 1
HJFUAQJBMRCZMD-UHFFFAOYSA-N ClC1(CCN=C1C(Cl)(Cl)Cl)Cl.ClC1=C(NC=C1)C(=O)OC Chemical compound ClC1(CCN=C1C(Cl)(Cl)Cl)Cl.ClC1=C(NC=C1)C(=O)OC HJFUAQJBMRCZMD-UHFFFAOYSA-N 0.000 description 1
XOZNRGLMJNOXRJ-MLBSPLJJSA-N ClC1=C(C(=CC=C1)[N+](=O)[O-])/C(/C(=O)OC)=C(/C)O.ClC1=C2C(=C(NC2=CC=C1)C)C(=O)OC Chemical compound ClC1=C(C(=CC=C1)[N+](=O)[O-])/C(/C(=O)OC)=C(/C)O.ClC1=C2C(=C(NC2=CC=C1)C)C(=O)OC XOZNRGLMJNOXRJ-MLBSPLJJSA-N 0.000 description 1
GLXXIWBRIGMIIZ-UHFFFAOYSA-N ClC1=C(NC2=CC=CC=C12)C(=O)NC1=CC=C2C=CN(C2=C1)CC(=O)OC(C)(C)C.ClC1=C2N(C=3C=CC=CC13)CCN(C2=O)C2=CC=C1C=CN(C1=C2)CC(=O)OC(C)(C)C Chemical compound ClC1=C(NC2=CC=CC=C12)C(=O)NC1=CC=C2C=CN(C2=C1)CC(=O)OC(C)(C)C.ClC1=C2N(C=3C=CC=CC13)CCN(C2=O)C2=CC=C1C=CN(C1=C2)CC(=O)OC(C)(C)C GLXXIWBRIGMIIZ-UHFFFAOYSA-N 0.000 description 1
MPDTWDBAWMJOCY-UHFFFAOYSA-N ClC1=C(NC2=CC=CC=C12)C(=O)OCC.ClC1=C(NC2=CC=CC=C12)C(=O)O Chemical compound ClC1=C(NC2=CC=CC=C12)C(=O)OCC.ClC1=C(NC2=CC=CC=C12)C(=O)O MPDTWDBAWMJOCY-UHFFFAOYSA-N 0.000 description 1
BIDPDZLWSWTXQH-UHFFFAOYSA-N ClC=1C=2C3=C(N(C2C=CC1)C)CN(C3=O)C3=CC=C1C=CN(C1=C3)CC(=O)OC(C)(C)C.ClC=3C=1C2=C(N(C1C=CC3)C)CN(C2=O)C2=CC=C3C=CN(C3=C2)CC(=O)O Chemical compound ClC=1C=2C3=C(N(C2C=CC1)C)CN(C3=O)C3=CC=C1C=CN(C1=C3)CC(=O)OC(C)(C)C.ClC=3C=1C2=C(N(C1C=CC3)C)CN(C2=O)C2=CC=C3C=CN(C3=C2)CC(=O)O BIDPDZLWSWTXQH-UHFFFAOYSA-N 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
208000032131 Diabetic Neuropathies Diseases 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
NQYJFZQVVCRVRE-UHFFFAOYSA-N FC(C(=O)N1CC2=CC=C(C=C2CC1)C=O)(F)F.FC(C(=O)N1CC2=CC=C(C=C2CC1)CN1CCCCC1)(F)F Chemical compound FC(C(=O)N1CC2=CC=C(C=C2CC1)C=O)(F)F.FC(C(=O)N1CC2=CC=C(C=C2CC1)CN1CCCCC1)(F)F NQYJFZQVVCRVRE-UHFFFAOYSA-N 0.000 description 1
CVANFUYTFFVKBG-UHFFFAOYSA-N FC(C(=O)N1CC2=CC=C(C=C2CC1)CN1CCCCC1)(F)F.Cl.Cl.N1(CCCCC1)CC=1C=C2CCNCC2=CC1 Chemical compound FC(C(=O)N1CC2=CC=C(C=C2CC1)CN1CCCCC1)(F)F.Cl.Cl.N1(CCCCC1)CC=1C=C2CCNCC2=CC1 CVANFUYTFFVKBG-UHFFFAOYSA-N 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
101000756551 Homo sapiens Acrosin-binding protein Proteins 0.000 description 1
108090001005 Interleukin-6 Proteins 0.000 description 1
108090001007 Interleukin-8 Proteins 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
229930182821 L-proline Natural products 0.000 description 1
239000002841 Lewis acid Substances 0.000 description 1
241000282553 Macaca Species 0.000 description 1
206010025421 Macule Diseases 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
239000012359 Methanesulfonyl chloride Substances 0.000 description 1
ULMHMJAEGZPQRY-UHFFFAOYSA-N N-(tert-butoxycarbonyl)piperidin-2-one Chemical compound CC(C)(C)OC(=O)N1CCCCC1=O ULMHMJAEGZPQRY-UHFFFAOYSA-N 0.000 description 1
OKJIRPAQVSHGFK-UHFFFAOYSA-N N-acetylglycine Chemical compound CC(=O)NCC(O)=O OKJIRPAQVSHGFK-UHFFFAOYSA-N 0.000 description 1
LYAVXWPXKIFHBU-UHFFFAOYSA-N N-{2-[(1,2-diphenylhydrazinyl)carbonyl]-2-hydroxyhexanoyl}-6-aminohexanoic acid Chemical compound C=1C=CC=CC=1N(C(=O)C(O)(C(=O)NCCCCCC(O)=O)CCCC)NC1=CC=CC=C1 LYAVXWPXKIFHBU-UHFFFAOYSA-N 0.000 description 1
SSNJBKDKTKQKIG-UHFFFAOYSA-N N1CCC(CC1)O.C(CC)(=O)O Chemical compound N1CCC(CC1)O.C(CC)(=O)O SSNJBKDKTKQKIG-UHFFFAOYSA-N 0.000 description 1
229910003204 NH2 Inorganic materials 0.000 description 1
101150020251 NR13 gene Proteins 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
208000000450 Pelvic Pain Diseases 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 1
YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
239000007868 Raney catalyst Substances 0.000 description 1
229910000564 Raney nickel Inorganic materials 0.000 description 1
WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
101100310674 Tenebrio molitor SP23 gene Proteins 0.000 description 1
229910010062 TiCl3 Inorganic materials 0.000 description 1
DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
UGDVICJWIGNCHF-UHFFFAOYSA-N [N+](=O)([O-])C=1C=CC=C2C=CNC12.C(C)(=O)O Chemical compound [N+](=O)([O-])C=1C=CC=C2C=CNC12.C(C)(=O)O UGDVICJWIGNCHF-UHFFFAOYSA-N 0.000 description 1
CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 1
OPFKMLLBILXFRV-UHFFFAOYSA-N acetic acid piperazine Chemical compound C(C)(=O)O.N1CCNCC1.N1CCNCC1 OPFKMLLBILXFRV-UHFFFAOYSA-N 0.000 description 1
ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000000556 agonist Substances 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
125000005275 alkylenearyl group Chemical group 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
229940024606 amino acid Drugs 0.000 description 1
VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 1
239000012300 argon atmosphere Substances 0.000 description 1
150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
YHYHRFICQWDJNZ-UHFFFAOYSA-N azanium ethanimidate Chemical compound N.CC(N)=O YHYHRFICQWDJNZ-UHFFFAOYSA-N 0.000 description 1
125000003725 azepanyl group Chemical group 0.000 description 1
HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
YQEAZZWFFGPPAM-UHFFFAOYSA-N benzaldehyde;dihydrochloride Chemical compound Cl.Cl.O=CC1=CC=CC=C1 YQEAZZWFFGPPAM-UHFFFAOYSA-N 0.000 description 1
150000001555 benzenes Chemical class 0.000 description 1
125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
GZXUPVALIYWMTB-UHFFFAOYSA-N benzyl 9-oxo-3-azaspiro[5.5]undec-10-ene-3-carboxylate Chemical compound C1CC2(C=CC(=O)CC2)CCN1C(=O)OCC1=CC=CC=C1 GZXUPVALIYWMTB-UHFFFAOYSA-N 0.000 description 1
UHBCLMREPHGSBL-UHFFFAOYSA-N benzyl 9-oxo-3-azaspiro[5.5]undec-10-ene-3-carboxylate;but-3-en-2-one Chemical compound CC(=O)C=C.C1CC2(C=CC(=O)CC2)CCN1C(=O)OCC1=CC=CC=C1 UHBCLMREPHGSBL-UHFFFAOYSA-N 0.000 description 1
PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 1
125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
125000002619 bicyclic group Chemical group 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
230000009460 calcium influx Effects 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000012876 carrier material Substances 0.000 description 1
PBAYDYUZOSNJGU-UHFFFAOYSA-N chelidonic acid Natural products OC(=O)C1=CC(=O)C=C(C(O)=O)O1 PBAYDYUZOSNJGU-UHFFFAOYSA-N 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
208000037976 chronic inflammation Diseases 0.000 description 1
208000037893 chronic inflammatory disorder Diseases 0.000 description 1
150000001860 citric acid derivatives Chemical class 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
125000004093 cyano group Chemical group *C#N 0.000 description 1
125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
MKJDUHZPLQYUCB-UHFFFAOYSA-N decan-4-one Chemical compound CCCCCCC(=O)CCC MKJDUHZPLQYUCB-UHFFFAOYSA-N 0.000 description 1
DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
125000005959 diazepanyl group Chemical group 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
229960001760 dimethyl sulfoxide Drugs 0.000 description 1
QHNXEVRKFKHMRL-UHFFFAOYSA-N dimethylazanium;acetate Chemical compound CNC.CC(O)=O QHNXEVRKFKHMRL-UHFFFAOYSA-N 0.000 description 1
UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
CEALXSHFPPCRNM-UHFFFAOYSA-L disodium;carboxylato carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OC([O-])=O CEALXSHFPPCRNM-UHFFFAOYSA-L 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
239000006196 drop Substances 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
210000001842 enterocyte Anatomy 0.000 description 1
LHWWETDBWVTKJO-UHFFFAOYSA-N et3n triethylamine Chemical compound CCN(CC)CC.CCN(CC)CC LHWWETDBWVTKJO-UHFFFAOYSA-N 0.000 description 1
BWZXLUXDHLCWNP-UHFFFAOYSA-N ethyl 2-(6-aminoindol-1-yl)acetate Chemical compound C1=C(N)C=C2N(CC(=O)OCC)C=CC2=C1 BWZXLUXDHLCWNP-UHFFFAOYSA-N 0.000 description 1
AOLHKGVLPBKBDP-UHFFFAOYSA-N ethyl 2-(6-aminoindol-1-yl)acetate ethyl 2-[6-(4-methyl-3-oxo-1H-isoindol-2-yl)indol-1-yl]acetate Chemical compound NC1=CC=C2C=CN(C2=C1)CC(=O)OCC.CC=1C=CC=C2CN(C(C12)=O)C1=CC=C2C=CN(C2=C1)CC(=O)OCC AOLHKGVLPBKBDP-UHFFFAOYSA-N 0.000 description 1
FTGJGRDEKZAXKU-UHFFFAOYSA-N ethyl 2-[6-(4-methyl-3-oxo-1h-isoindol-2-yl)indol-1-yl]acetate Chemical compound C1C2=CC=CC(C)=C2C(=O)N1C1=CC=C2C=CN(CC(=O)OCC)C2=C1 FTGJGRDEKZAXKU-UHFFFAOYSA-N 0.000 description 1
OJCSPXHYDFONPU-UHFFFAOYSA-N etoac etoac Chemical compound CCOC(C)=O.CCOC(C)=O OJCSPXHYDFONPU-UHFFFAOYSA-N 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000000945 filler Substances 0.000 description 1
125000001207 fluorophenyl group Chemical group 0.000 description 1
239000012909 foetal bovine serum Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
FATAVLOOLIRUNA-UHFFFAOYSA-N formylmethyl Chemical group [CH2]C=O FATAVLOOLIRUNA-UHFFFAOYSA-N 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000012362 glacial acetic acid Substances 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
230000005484 gravity Effects 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
229940093915 gynecological organic acid Drugs 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
FYAQQULBLMNGAH-UHFFFAOYSA-N hexane-1-sulfonic acid Chemical compound CCCCCCS(O)(=O)=O FYAQQULBLMNGAH-UHFFFAOYSA-N 0.000 description 1
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
235000009200 high fat diet Nutrition 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
238000007327 hydrogenolysis reaction Methods 0.000 description 1
BNTRVUUJBGBGLZ-UHFFFAOYSA-N hydron;pyridine-4-carbonyl chloride;chloride Chemical compound Cl.ClC(=O)C1=CC=NC=C1 BNTRVUUJBGBGLZ-UHFFFAOYSA-N 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
239000005457 ice water Substances 0.000 description 1
239000007943 implant Substances 0.000 description 1
125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
239000011261 inert gas Substances 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
229910000358 iron sulfate Inorganic materials 0.000 description 1
BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
PXZQEOJJUGGUIB-UHFFFAOYSA-N isoindolin-1-one Chemical compound C1=CC=C2C(=O)NCC2=C1 PXZQEOJJUGGUIB-UHFFFAOYSA-N 0.000 description 1
SRJOCJYGOFTFLH-UHFFFAOYSA-N isonipecotic acid Chemical compound OC(=O)C1CCNCC1 SRJOCJYGOFTFLH-UHFFFAOYSA-N 0.000 description 1
125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
ULYZAYCEDJDHCC-UHFFFAOYSA-N isopropyl chloride Chemical compound CC(C)Cl ULYZAYCEDJDHCC-UHFFFAOYSA-N 0.000 description 1
125000000842 isoxazolyl group Chemical group 0.000 description 1
238000011813 knockout mouse model Methods 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
150000007517 lewis acids Chemical class 0.000 description 1
239000003446 ligand Substances 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
239000008297 liquid dosage form Substances 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
HPSHEKVARRIWLU-UHFFFAOYSA-M lithium;propane-1-thiolate Chemical compound [Li+].CCC[S-] HPSHEKVARRIWLU-UHFFFAOYSA-M 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
229960002510 mandelic acid Drugs 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
BBOHTKUNGJITNJ-MLBSPLJJSA-N methyl (E)-2-(2-chloro-6-nitrophenyl)-3-hydroxybut-2-enoate methyl 3-oxobutanoate Chemical compound C(CC(=O)C)(=O)OC.ClC1=C(C(=CC=C1)[N+](=O)[O-])/C(/C(=O)OC)=C(/C)O BBOHTKUNGJITNJ-MLBSPLJJSA-N 0.000 description 1
UXXOZFSGKVQPMV-UHFFFAOYSA-N methyl 2-(bromomethyl)-4-chloro-1-methylindole-3-carboxylate methyl 4-chloro-1,2-dimethylindole-3-carboxylate Chemical compound ClC1=C2C(=C(N(C2=CC=C1)C)C)C(=O)OC.BrCC=1N(C2=CC=CC(=C2C1C(=O)OC)Cl)C UXXOZFSGKVQPMV-UHFFFAOYSA-N 0.000 description 1
KNFATGQNJHQJGL-UHFFFAOYSA-N methyl 4-chloro-1,2-dimethylindole-3-carboxylate methyl 4-chloro-2-methyl-1H-indole-3-carboxylate Chemical compound ClC1=C2C(=C(NC2=CC=C1)C)C(=O)OC.ClC1=C2C(=C(N(C2=CC=C1)C)C)C(=O)OC KNFATGQNJHQJGL-UHFFFAOYSA-N 0.000 description 1
JQSLLLFOWQMQHH-UHFFFAOYSA-N methyl 4-chloro-1-methyl-2-[[[1-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]indol-6-yl]amino]methyl]indole-3-carboxylate Chemical compound CN1C2=CC=CC(Cl)=C2C(C(=O)OC)=C1CNC1=CC=C(C=CN2CC(=O)OC(C)(C)C)C2=C1 JQSLLLFOWQMQHH-UHFFFAOYSA-N 0.000 description 1
LSEFCHWGJNHZNT-UHFFFAOYSA-M methyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 LSEFCHWGJNHZNT-UHFFFAOYSA-M 0.000 description 1
GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
MXWHMTNPTTVWDM-NXOFHUPFSA-N mitoguazone Chemical compound NC(N)=N\N=C(/C)\C=N\N=C(N)N MXWHMTNPTTVWDM-NXOFHUPFSA-N 0.000 description 1
125000002757 morpholinyl group Chemical group 0.000 description 1
LUEQQZZOGSYPIX-UHFFFAOYSA-N n,n-dimethyl-1-[3-(methylamino)propyl]-4-phenylpiperidin-4-amine;trihydrochloride Chemical compound Cl.Cl.Cl.C1CN(CCCNC)CCC1(N(C)C)C1=CC=CC=C1 LUEQQZZOGSYPIX-UHFFFAOYSA-N 0.000 description 1
CQSSFTURJRYVGN-UHFFFAOYSA-N n,n-dimethyl-1-[3-(methylamino)propyl]-4-thiophen-2-ylpiperidin-4-amine Chemical compound C1CN(CCCNC)CCC1(N(C)C)C1=CC=CS1 CQSSFTURJRYVGN-UHFFFAOYSA-N 0.000 description 1
JMSLKESKTAAQCQ-UHFFFAOYSA-N n,n-dimethyl-1-[3-(methylamino)propyl]-4-thiophen-2-ylpiperidin-4-amine;trihydrochloride Chemical compound Cl.Cl.Cl.C1CN(CCCNC)CCC1(N(C)C)C1=CC=CS1 JMSLKESKTAAQCQ-UHFFFAOYSA-N 0.000 description 1
FPDOJGKESMGNFT-UHFFFAOYSA-N n,n-dimethyl-4-[2-(methylamino)ethyl]-1-phenylcyclohexan-1-amine Chemical compound C1CC(CCNC)CCC1(N(C)C)C1=CC=CC=C1 FPDOJGKESMGNFT-UHFFFAOYSA-N 0.000 description 1
YNTOKMNHRPSGFU-UHFFFAOYSA-N n-Propyl carbamate Chemical compound CCCOC(N)=O YNTOKMNHRPSGFU-UHFFFAOYSA-N 0.000 description 1
GQOADJIBOFOGTQ-UHFFFAOYSA-N n-[1-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-oxoethyl]indol-7-yl]-4-methoxy-2,6-dimethylbenzenesulfonamide Chemical compound CC1=CC(OC)=CC(C)=C1S(=O)(=O)NC1=CC=CC2=C1N(CC(=O)N1CCC(CC1)(N(C)C)C=1SC=CC=1)C=C2 GQOADJIBOFOGTQ-UHFFFAOYSA-N 0.000 description 1
WIPDCTVEAHMFGB-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]ethyl]-2-[7-[(4-methoxy-2,6-dimethylphenyl)sulfonylamino]indol-1-yl]acetamide Chemical compound CC1=CC(OC)=CC(C)=C1S(=O)(=O)NC1=CC=CC2=C1N(CC(=O)NCCN1CCC(CC1)(N(C)C)C=1SC=CC=1)C=C2 WIPDCTVEAHMFGB-UHFFFAOYSA-N 0.000 description 1
ACNBFOADHGAWAR-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]propyl]-2-[7-[(4-methoxy-2,6-dimethylphenyl)sulfonylamino]indol-1-yl]-n-methylacetamide Chemical compound CC1=CC(OC)=CC(C)=C1S(=O)(=O)NC1=CC=CC2=C1N(CC(=O)N(C)CCCN1CCC(CC1)(N(C)C)C=1C=CC=CC=1)C=C2 ACNBFOADHGAWAR-UHFFFAOYSA-N 0.000 description 1
FODDKFROKUMUFL-UHFFFAOYSA-N n-[4-(azetidin-1-yl)-4-phenylcyclohexylidene]hydroxylamine Chemical compound C1CC(=NO)CCC1(C=1C=CC=CC=1)N1CCC1 FODDKFROKUMUFL-UHFFFAOYSA-N 0.000 description 1
IDXDWGXYFULPEU-UHFFFAOYSA-N n-[[4-(4-methylpiperazin-1-yl)piperidin-4-yl]methyl]pyridine-4-carboxamide Chemical compound C1CN(C)CCN1C1(CNC(=O)C=2C=CN=CC=2)CCNCC1 IDXDWGXYFULPEU-UHFFFAOYSA-N 0.000 description 1
WOOWBQQQJXZGIE-UHFFFAOYSA-N n-ethyl-n-propan-2-ylpropan-2-amine Chemical compound CCN(C(C)C)C(C)C.CCN(C(C)C)C(C)C WOOWBQQQJXZGIE-UHFFFAOYSA-N 0.000 description 1
DPQLNXZJVZMSLR-UHFFFAOYSA-N n-methyl-3-(4-pyridin-4-ylpiperazin-1-yl)propan-1-amine Chemical compound C1CN(CCCNC)CCN1C1=CC=NC=C1 DPQLNXZJVZMSLR-UHFFFAOYSA-N 0.000 description 1
125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
230000003448 neutrophilic effect Effects 0.000 description 1
PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
229960003512 nicotinic acid Drugs 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
235000006408 oxalic acid Nutrition 0.000 description 1
JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 1
150000002923 oximes Chemical class 0.000 description 1
BSCHIACBONPEOB-UHFFFAOYSA-N oxolane;hydrate Chemical compound O.C1CCOC1 BSCHIACBONPEOB-UHFFFAOYSA-N 0.000 description 1
235000010603 pastilles Nutrition 0.000 description 1
230000001991 pathophysiological effect Effects 0.000 description 1
239000008188 pellet Substances 0.000 description 1
230000035515 penetration Effects 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
ANRQGKOBLBYXFM-UHFFFAOYSA-M phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 description 1
125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
125000004193 piperazinyl group Chemical group 0.000 description 1
239000011505 plaster Substances 0.000 description 1
229920001992 poloxamer 407 Polymers 0.000 description 1
125000003367 polycyclic group Chemical group 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
229910000343 potassium bisulfate Inorganic materials 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
229960002429 proline Drugs 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
201000007094 prostatitis Diseases 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
239000008213 purified water Substances 0.000 description 1
125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
125000003226 pyrazolyl group Chemical group 0.000 description 1
BGUWFUQJCDRPTL-UHFFFAOYSA-N pyridine-4-carbaldehyde Chemical compound O=CC1=CC=NC=C1 BGUWFUQJCDRPTL-UHFFFAOYSA-N 0.000 description 1
125000001422 pyrrolinyl group Chemical group 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000010791 quenching Methods 0.000 description 1
230000000171 quenching effect Effects 0.000 description 1
125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
230000006884 regulation of angiogenesis Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
102220008337 rs1437698471 Human genes 0.000 description 1
239000000523 sample Substances 0.000 description 1
230000007017 scission Effects 0.000 description 1
239000008299 semisolid dosage form Substances 0.000 description 1
ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
239000012279 sodium borohydride Substances 0.000 description 1
229910000033 sodium borohydride Inorganic materials 0.000 description 1
239000007858 starting material Substances 0.000 description 1
229960002317 succinimide Drugs 0.000 description 1
230000006103 sulfonylation Effects 0.000 description 1
238000005694 sulfonylation reaction Methods 0.000 description 1
235000011149 sulphuric acid Nutrition 0.000 description 1
238000001308 synthesis method Methods 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000006188 syrup Substances 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
UXAWXZDXVOYLII-UHFFFAOYSA-N tert-butyl 2,5-diazabicyclo[2.2.1]heptane-2-carboxylate Chemical compound C1C2N(C(=O)OC(C)(C)C)CC1NC2 UXAWXZDXVOYLII-UHFFFAOYSA-N 0.000 description 1
NFNCPNAVNRBDOU-UHFFFAOYSA-N tert-butyl 2,8-diazaspiro[4.5]decane-2-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC21CCNCC2 NFNCPNAVNRBDOU-UHFFFAOYSA-N 0.000 description 1
XEGKJGBPQYDCHQ-UHFFFAOYSA-N tert-butyl 2-[5-(8-chloro-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazin-2-yl)indol-1-yl]acetate Chemical compound C1CN2C=CC(Cl)=C2C(=O)N1C1=CC=C2N(CC(=O)OC(C)(C)C)C=CC2=C1 XEGKJGBPQYDCHQ-UHFFFAOYSA-N 0.000 description 1
HSEUWVARERFSPN-UHFFFAOYSA-N tert-butyl 2-[5-[(3-chloro-1h-pyrrole-2-carbonyl)amino]indol-1-yl]acetate Chemical compound C=1C=C2N(CC(=O)OC(C)(C)C)C=CC2=CC=1NC(=O)C=1NC=CC=1Cl HSEUWVARERFSPN-UHFFFAOYSA-N 0.000 description 1
MKGJOINZXPDYRY-UHFFFAOYSA-N tert-butyl 2-[6-(8-chloro-4-methyl-1-oxo-3h-pyrrolo[3,4-b]indol-2-yl)indol-1-yl]acetate Chemical compound C1=C2C=CN(CC(=O)OC(C)(C)C)C2=CC(N2CC=3N(C4=CC=CC(Cl)=C4C=3C2=O)C)=C1 MKGJOINZXPDYRY-UHFFFAOYSA-N 0.000 description 1
MSHRLMJZGKPOKG-UHFFFAOYSA-N tert-butyl 2-[6-[(3-chloro-1h-indole-2-carbonyl)amino]indol-1-yl]acetate Chemical compound N1C2=CC=CC=C2C(Cl)=C1C(=O)NC1=CC=C2C=CN(CC(=O)OC(C)(C)C)C2=C1 MSHRLMJZGKPOKG-UHFFFAOYSA-N 0.000 description 1
YLKHACHFJMCIRE-UHFFFAOYSA-N tert-butyl 3,9-diazaspiro[5.5]undecane-3-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC11CCNCC1 YLKHACHFJMCIRE-UHFFFAOYSA-N 0.000 description 1
IYLVXJHBTTUFBU-UHFFFAOYSA-N tert-butyl 3-[6-(piperidin-1-ylmethyl)-3,4-dihydro-1h-isoquinolin-2-yl]pyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1N1CC2=CC=C(CN3CCCCC3)C=C2CC1 IYLVXJHBTTUFBU-UHFFFAOYSA-N 0.000 description 1
JSOMVCDXPUXKIC-UHFFFAOYSA-N tert-butyl 3-oxopyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=O)C1 JSOMVCDXPUXKIC-UHFFFAOYSA-N 0.000 description 1
HJFVSMSJQDZEAC-UHFFFAOYSA-N tert-butyl 3-pyridin-4-yl-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-8-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC11ON=C(C=2C=CN=CC=2)C1 HJFVSMSJQDZEAC-UHFFFAOYSA-N 0.000 description 1
FXVUWJJCTNMRII-UHFFFAOYSA-N tert-butyl 4-(dimethylamino)-4-thiophen-2-ylpiperidine-1-carboxylate Chemical compound C=1C=CSC=1C1(N(C)C)CCN(C(=O)OC(C)(C)C)CC1 FXVUWJJCTNMRII-UHFFFAOYSA-N 0.000 description 1
PWQLFIKTGRINFF-UHFFFAOYSA-N tert-butyl 4-hydroxypiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(O)CC1 PWQLFIKTGRINFF-UHFFFAOYSA-N 0.000 description 1
XVEMOXGZBPJMEF-UHFFFAOYSA-N tert-butyl 5-(pyridin-4-ylmethyl)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate Chemical compound CC(C)(C)OC(=O)N1CC2CC1CN2CC1=CC=NC=C1 XVEMOXGZBPJMEF-UHFFFAOYSA-N 0.000 description 1
LTXIBCSKSXOPME-UHFFFAOYSA-N tert-butyl 9-(3,3-difluoroazetidin-1-yl)-3-azaspiro[5.5]undecane-3-carboxylate 9-(3,3-difluoroazetidin-1-yl)-3-azaspiro[5.5]undecane dihydrochloride Chemical compound Cl.Cl.FC1(F)CN(C1)C1CCC2(CCNCC2)CC1.CC(C)(C)OC(=O)N1CCC2(CCC(CC2)N2CC(F)(F)C2)CC1 LTXIBCSKSXOPME-UHFFFAOYSA-N 0.000 description 1
ZECQEKVQHNGBGJ-UHFFFAOYSA-N tert-butyl 9-(3,3-difluoroazetidin-1-yl)-3-azaspiro[5.5]undecane-3-carboxylate tert-butyl 9-oxo-3-azaspiro[5.5]undecane-3-carboxylate Chemical compound O=C1CCC2(CCN(CC2)C(=O)OC(C)(C)C)CC1.FC1(CN(C1)C1CCC2(CCN(CC2)C(=O)OC(C)(C)C)CC1)F ZECQEKVQHNGBGJ-UHFFFAOYSA-N 0.000 description 1
FSLACBHLAPRFTN-UHFFFAOYSA-N tert-butyl 9-(azetidin-1-yl)-3-azaspiro[5.5]undecane-3-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC11CCC(N2CCC2)CC1 FSLACBHLAPRFTN-UHFFFAOYSA-N 0.000 description 1
HOOPVDUZNGSHSB-UHFFFAOYSA-N tert-butyl 9-(azetidin-1-yl)-3-azaspiro[5.5]undecane-3-carboxylate tert-butyl 9-oxo-3-azaspiro[5.5]undecane-3-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC2(CC1)CCC(=O)CC2.CC(C)(C)OC(=O)N1CCC2(CCC(CC2)N2CCC2)CC1 HOOPVDUZNGSHSB-UHFFFAOYSA-N 0.000 description 1
NAFAKXTXWZJGHD-UHFFFAOYSA-N tert-butyl 9-hydroxy-3-azaspiro[5.5]undecane-3-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC11CCC(O)CC1 NAFAKXTXWZJGHD-UHFFFAOYSA-N 0.000 description 1
UXZBTEIHIQFMIT-UHFFFAOYSA-N tert-butyl 9-oxo-3-azaspiro[5.5]undecane-3-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC21CCC(=O)CC2 UXZBTEIHIQFMIT-UHFFFAOYSA-N 0.000 description 1
LWNBJUJDDGCWAP-UHFFFAOYSA-N tert-butyl 9-pyridin-4-yl-3,9-diazaspiro[5.5]undecane-3-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC21CCN(C=1C=CN=CC=1)CC2 LWNBJUJDDGCWAP-UHFFFAOYSA-N 0.000 description 1
XSWYGQRMBWSBGN-UHFFFAOYSA-N tert-butyl 9-pyridin-4-yloxy-3-azaspiro[5.5]undecane-3-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC11CCC(OC=2C=CN=CC=2)CC1 XSWYGQRMBWSBGN-UHFFFAOYSA-N 0.000 description 1
WMOVHXAZOJBABW-UHFFFAOYSA-N tert-butyl acetate Chemical group CC(=O)OC(C)(C)C WMOVHXAZOJBABW-UHFFFAOYSA-N 0.000 description 1
TZRQZPMQUXEZMC-UHFFFAOYSA-N tert-butyl n-(2-bromoethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCBr TZRQZPMQUXEZMC-UHFFFAOYSA-N 0.000 description 1
NJRUSULBGRULMH-UHFFFAOYSA-N tert-butyl n-[(1-pyridin-4-ylpiperidin-4-yl)methyl]carbamate Chemical compound C1CC(CNC(=O)OC(C)(C)C)CCN1C1=CC=NC=C1 NJRUSULBGRULMH-UHFFFAOYSA-N 0.000 description 1
IPCHJZXMHXHOKV-UHFFFAOYSA-N tert-butyl n-[2-(1-pyridin-4-ylpiperidin-4-yl)ethyl]carbamate Chemical compound C1CC(CCNC(=O)OC(C)(C)C)CCN1C1=CC=NC=C1 IPCHJZXMHXHOKV-UHFFFAOYSA-N 0.000 description 1
VUIUAIFYQUYFQX-UHFFFAOYSA-N tert-butyl n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]propyl]-n-methylcarbamate Chemical compound C1CN(CCCN(C)C(=O)OC(C)(C)C)CCC1(N(C)C)C1=CC=CC=C1 VUIUAIFYQUYFQX-UHFFFAOYSA-N 0.000 description 1
TWKSNLQQGGOJDN-UHFFFAOYSA-N tert-butyl n-[3-[tert-butyl(dimethyl)silyl]oxypropyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCO[Si](C)(C)C(C)(C)C TWKSNLQQGGOJDN-UHFFFAOYSA-N 0.000 description 1
238000012360 testing method Methods 0.000 description 1
150000003536 tetrazoles Chemical class 0.000 description 1
WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
125000002769 thiazolinyl group Chemical group 0.000 description 1
YONPGGFAJWQGJC-UHFFFAOYSA-K titanium(iii) chloride Chemical compound Cl[Ti](Cl)Cl YONPGGFAJWQGJC-UHFFFAOYSA-K 0.000 description 1
150000003852 triazoles Chemical class 0.000 description 1
GGUBFICZYGKNTD-UHFFFAOYSA-N triethyl phosphonoacetate Chemical compound CCOC(=O)CP(=O)(OCC)OCC GGUBFICZYGKNTD-UHFFFAOYSA-N 0.000 description 1
QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 1
230000003827 upregulation Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Hematology (AREA)
Obesity (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Immunology (AREA)
Emergency Medicine (AREA)
Oncology (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pyridine Compounds (AREA)

CA2751402A 2009-02-04 2010-02-02 Composes d'indol substitues en tant que modulateurs du recepteur 1 de la bradykinine Abandoned CA2751402A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP09001488.7		2009-02-04
EP09001488		2009-02-04
PCT/EP2010/000630 WO2010089084A1 (fr)	2009-02-04	2010-02-02	Composés d'indol substitués en tant que modulateurs du récepteur 1 de la bradykinine

Publications (1)

Publication Number	Publication Date
CA2751402A1 true CA2751402A1 (fr)	2010-08-12

Family

ID=40839539

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2751402A Abandoned CA2751402A1 (fr)	2009-02-04	2010-02-02	Composes d'indol substitues en tant que modulateurs du recepteur 1 de la bradykinine

Country Status (10)

Country	Link
US (1)	US8492559B2 (fr)
EP (1)	EP2393803A1 (fr)
JP (1)	JP2012516860A (fr)
AR (1)	AR074967A1 (fr)
AU (1)	AU2010211251A1 (fr)
BR (1)	BRPI1011522A2 (fr)
CA (1)	CA2751402A1 (fr)
MX (1)	MX2011008126A (fr)
TW (1)	TW201031665A (fr)
WO (1)	WO2010089084A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN104203951B (zh)	2012-03-16	2016-11-02	生命医药公司	肝x受体调节剂
WO2013138568A1 (fr)	2012-03-16	2013-09-19	Vitae Pharmaceuticals, Inc.	Modulateurs du récepteur x du foie
CN104945416B (zh) *	2014-03-24	2017-11-17	中国科学院上海药物研究所	一类螺异噁唑啉衍生物、其制备方法及医药用途
GB201519195D0 (en) *	2015-10-30	2015-12-16	Heptares Therapeutics Ltd	CGRP Receptor Antagonists
CN112573978B (zh) *	2019-09-30	2022-05-13	北京大学	一种芳基卤化物的高效卤化合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6147106A (en) *	1997-08-20	2000-11-14	Sugen, Inc.	Indolinone combinatorial libraries and related products and methods for the treatment of disease
AU4055300A (en) *	1999-04-02	2000-10-23	Neurogen Corporation	Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of Bradykinin B2 receptors
GB0017256D0 (en)	2000-07-13	2000-08-30	Merck Sharp & Dohme	Therapeutic agents
EP1547596A4 (fr) *	2002-09-06	2008-11-19	Western Therapeutics Inst Inc	Composition medicamenteuse et methode de traitement des tumeurs malignes et d'utilisation de ladite composition medicamenteuse
EP1600447A1 (fr)	2004-05-28	2005-11-30	Neuropharma S.A.U.	Inhibiteurs de butyrylcholinestérase selective
US20060128765A1 (en) *	2004-12-10	2006-06-15	Wood Michael R	2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation
WO2007101007A2 (fr)	2006-02-23	2007-09-07	Neurogen Corporation	Heterocycles sulfonyl aryliques
WO2007140383A2 (fr)	2006-05-30	2007-12-06	Neurogen Corporation	Sulfonamides spirocycliques et composés apparentés
WO2008033739A2 (fr) *	2006-09-12	2008-03-20	Neurogen Corporation	Dérivés de benzimidazolecarboxamide
RU2462464C2 (ru)	2006-09-29	2012-09-27	Грюненталь Гмбх	Замещенные сульфамидные производные
JP5406722B2 (ja)	2006-10-16	2014-02-05	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	ブラジキニン１受容体モジュレータとしての置換されたスルホンアミド誘導体

2010
- 2010-01-15 TW TW099101012A patent/TW201031665A/zh unknown
- 2010-01-29 AR ARP100100246A patent/AR074967A1/es not_active Application Discontinuation
- 2010-02-02 WO PCT/EP2010/000630 patent/WO2010089084A1/fr not_active Ceased
- 2010-02-02 MX MX2011008126A patent/MX2011008126A/es not_active Application Discontinuation
- 2010-02-02 EP EP10703016A patent/EP2393803A1/fr not_active Withdrawn
- 2010-02-02 JP JP2011548590A patent/JP2012516860A/ja not_active Withdrawn
- 2010-02-02 BR BRPI1011522A patent/BRPI1011522A2/pt not_active IP Right Cessation
- 2010-02-02 CA CA2751402A patent/CA2751402A1/fr not_active Abandoned
- 2010-02-02 AU AU2010211251A patent/AU2010211251A1/en not_active Abandoned
- 2010-02-03 US US12/699,451 patent/US8492559B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BRPI1011522A2 (pt)	2016-03-29
US20100222324A1 (en)	2010-09-02
US8492559B2 (en)	2013-07-23
AU2010211251A1 (en)	2011-09-29
JP2012516860A (ja)	2012-07-26
WO2010089084A1 (fr)	2010-08-12
EP2393803A1 (fr)	2011-12-14
TW201031665A (en)	2010-09-01
MX2011008126A (es)	2011-08-17
AR074967A1 (es)	2011-02-23

Legal Events

Date	Code	Title	Description
2012-03-12	EEER	Examination request
2015-01-28	FZDE	Discontinued	Effective date: 20141203

Publication	Publication Date	Title
EP2403854A1 (fr)	2012-01-11	Tétrahydroazolopyrazines sulfonylées et leur utilisation en tant que produits médicamenteux
AU2007304475B2 (en)	2012-07-26	Substituted sulfonamide derivatives
US8269000B2 (en)	2012-09-18	Substituted pyrimidine and triazine compounds
US8669266B2 (en)	2014-03-11	Quinoline-carboxamide derivatives as P2Y12 antagonists
EP2393812B1 (fr)	2013-07-03	Spiroamides substitués en tant que modulateurs du b1r
US8232288B2 (en)	2012-07-31	Substituted benzimidazoles, benzothiazoles and benzoxazoles
AU2009313093A1 (en)	2011-06-30	Substituted disulfonamides as BRI-modulators
CA2741709A1 (fr)	2010-05-06	Spiroamines substituees
CA2751402A1 (fr)	2010-08-12	Composes d'indol substitues en tant que modulateurs du recepteur 1 de la bradykinine
CA2720879A1 (fr)	2009-10-15	Derives substitues de sulfonamide
US20100125078A1 (en)	2010-05-20	Quinazoline derivatives as nk3 receptor antagonists
HK1160450B (en)	2014-04-17	Sulfonylated tetrahydroazolopyrazines and their use as medicinal products